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Abstract 18 
Klebsiella pneumoniae is a Gram-negative facultative anaerobe that metabolizes 19 
glycerol efficiently under both aerobic and anaerobic conditions. This microbe is considered 20 
an outstanding biocatalyst for transforming glycerol into a variety of value-added products. 21 
Crude glycerol is a cheap carbon source and can be converted by K. pneumoniae into useful 22 
compounds such as lactic acid, 3-hydroxypropionic acid, ethanol, 1,3-propanediol, 2,3-23 
butanediol, and succinic acid. This review summarizes glycerol metabolism in K. 24 
pneumoniae and its potential as a microbial cell factory for the production of commercially 25 
important acids and alcohols. Although many challenges remain, K. pneumoniae is a 26 
promising workhorse when glycerol is used as the carbon source.  27 
Key words: Klebsiella pneumoniae; Glycerol; 3-Hydroxypropionic acid; 1,3-Propanediol; 28 
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1. Introduction 30 
Crude glycerol is produced in large quantities as a byproduct of the biodiesel industry. 31 
Global biodiesel production was 22.7 million tons in 2012 and is forecasted to reach 36.9 32 
million tons by 2020. As a result, worldwide production of glycerol climbed from 1 million 33 
tons in 2000 to 3 million tons in 2011 and is expected to reach 6 million tons by 2025 34 
(Ciriminna et al., 2014; OECD, 2011; Katryniok et al., 2013; Sun et al. 2017). A significant 35 
amount of glycerol is also generated during bioethanol fermentation by yeast. The liquid 36 
fraction of the stillage obtained from ethanol separation contains up to 2% glycerol. Another 37 
source of glycerol is industrial waste generated from vegetable oils and animal fats. For 38 
example, the concentration of glycerol in waste streams from the oleochemical industry is 39 
55%–90% (da Silva et al., 2009; Yazdani and Gonzalez, 2007). The increased availability of 40 
glycerol has caused a substantial reduction in its cost. According to a recent report, the price 41 
of crude glycerol is $0.24/kg and that of pure USP grade glycerol is $0.9/kg (Kong et al., 42 
2016). Extensive research has been conducted to investigate ways to utilize this surplus crude 43 
glycerol. The annual number of research articles addressing the use of glycerol has increased 44 
to >7000, doubling in number from the year 2000 to 2007. Numerous chemical conversions 45 
to valuable products have been reported (Ciriminna et al., 2014). 46 
Glycerol can be used for the microbial production of 1,3-propanediol (PDO), ethanol, 47 
2,3-butanediol (BDO), butanol, lactic acid, 3-hydroxypropionic acid (3-HP), and succinic 48 
acid (Fig. 1) (Clomberg and Gonzalez, 2013; Mattam et al., 2013; Yazdani and Gonzalez, 49 
2007). Because of its reduced nature, glycerol generates twice the number of reducing 50 
equivalents per carbon than do traditional carbohydrates (glucose, xylose, and sucrose) when 51 
converted into the glycolytic intermediates phosphoenolpyruvate (PEP) or pyruvate 52 
(Dharmadi et al., 2006). As a consequence, glycerol gives higher yields of reduced 53 
metabolites (e.g., succinate, ethanol, PDO, and butanol) than does glucose (Yazdani and 54 
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Gonzalez, 2007). Table 1 compares the maximum theoretical yield of various metabolites, 55 
ATP, and redox balances between glycerol and glucose.  56 
Despite its great potential as a carbon source, glycerol is not efficiently metabolized 57 
by many microorganisms under anaerobic or oxygen-limited conditions. The ability of K. 58 
pneumoniae to assimilate glycerol under oxygen-limited conditions is outstanding and has 59 
been studied extensively. Several review articles addressing this issue have also been 60 
published (Clomberg and Gonzalez, 2013; Mattam et al., 2013; Yazdani and Gonzalez, 2007), 61 
but the biotechnological potential and physiological aspects of this strain have not been fully 62 
elucidated. This review explores and discusses glycerol metabolism in K. pneumoniae and the 63 
production of value-added chemicals from glycerol. The potential and challenges of using K. 64 
pneumoniae as a microbial cell factory are also discussed. 65 
2. Glycerol metabolism in K. pneumoniae 66 
Many microorganisms can metabolize glycerol in the presence of external electron 67 
acceptors (respiratory metabolism), but relatively few under non-respiratory conditions 68 
(without exogenous electron acceptors). Among the latter, genera including Citrobacter, 69 
Enterobacter, Bacillus, Propionibacterium, Anaerobiospirillum, Klebsiella, Clostridium, and 70 
Lactobacillus are well documented (da Silva et al., 2009; Yazdani and Gonzalez, 2007). 71 
Some Lactobacillus species including L. reuteri, L. brevis, and L. bucheneri convert glycerol 72 
to PDO but only in the presence of a major carbon source for growth. Glycerol does not 73 
support cell growth, limiting its biotechnological applications. In contrast, Clostridium sp. 74 
grow well on glycerol as the sole carbon source. However, the use of Clostridium is limited 75 
by its slow growth and requirement of strict anaerobic conditions. The lack of a convenient 76 
genetic tool box for large-scale metabolic engineering is another serious drawback of 77 
Clostridium (Branduardi et al., 2014; Lütke-Eversloh and Bahl, 2011).  78 
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From a biotechnological standpoint, Klebsiella sp., especially K. pneumoniae, have 79 
many advantages over the aforementioned microbes. They grow on glycerol as the sole 80 
carbon source under both aerobic and anaerobic conditions (Arasu et al., 2011; Kumar et al., 81 
2012). Their growth is fast, typically growing at a rate >0.9/h, even on glycerol minimal 82 
medium (Arasu et al., 2011). They naturally produce coenzyme B12, an essential cofactor for 83 
the synthesis of the commercially important chemicals PDO and 3-HP (Huang et al., 2013a; 84 
Oh et al., 2012a). Furthermore, their evolutionary and biochemical proximity to E. coli allows 85 
for the application of most of gene manipulation methods developed for E. coli without much 86 
modification (Celińska, 2012; Kumar et al., 2013a). 87 
2.1 Overview of glycerol metabolism in K. pneumoniae 88 
In K. pneumoniae, glycerol is metabolized oxidatively and/or reductively (Ashok et 89 
al., 2011, Kumar et al., 2013a). The oxidative pathway provides energy and carbon 90 
constituents for the synthesis of cell biomass, while the reductive pathway reduces glycerol 91 
and regenerates NAD
+
, enabling the oxidative assimilation of glycerol under anaerobic 92 
conditions.  93 
Glycerol oxidation proceeds in either a respiratory or a fermentative manner. 94 
Respiration requires an exogenous electron acceptor such as oxygen, nitrate, or fumarate 95 
(Ashok et al., 2013a,b) and is carried out by enzymes encoded by the glp regulon. During 96 
respiration, glycerol is first phosphorylated by glycerol kinase (glpK) to yield sn-glycerol-3-97 
phosphate using ATP or phosphoenolpyruvate (PEP) as a phosphate donor. Next, sn-98 
glycerol-3-phosphate is oxidized to dihydroxyacetone phosphate (DHAP) with electron 99 
transfer to a quinone molecule, which is linked to the electron transport chain (ETC). This 100 
transformation is catalyzed by glycerol-3-phosphate dehydrogenase, which is expressed 101 
under both aerobic (glpD) and anaerobic (glpABC) conditions. In contrast, fermentation of 102 
glycerol is conducted without a supply of external electron acceptors, and the reactions are 103 
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catalyzed by enzymes encoded by the dha regulon. Here, glycerol is oxidized to 104 
dihydroxyacetone (DHA) by glycerol dehydrogenase (mainly encoded by dhaD) using NAD
+
 105 
as an electron acceptor. DHA then is phosphorylated by dihydroxyacetone kinase, an enzyme 106 
encoded by the ATP-dependent dhaK1/dhaK and/or PEP-dependent 107 
dhaK2/dhaKLM/dhaK123. DHAP obtained from respiration and/or fermentation is channeled 108 
into the glycolytic pathway (Fig. 2). A variety of organic acids and alcohols, including acetic 109 
acid, lactic acid, succinic acid, ethanol, BDO, and formic acid, are produced by the 110 
downstream glycolytic pathway (Ashok et al., 2011; Kumar et al., 2013a).  111 
The anaerobic growth capability of K. pneumoniae using glycerol as a carbon source 112 
is attributed to its well-established reductive metabolism. In the reductive pathway, glycerol 113 
first undergoes a difficult rearrangement reaction catalyzed by glycerol dehydratase (GDHt) 114 
to yield 3-hydroxypropioaldehyde (3-HPA). Catalysis by GDHt requires coenzyme B12, the 115 
de novo synthesis of which is limited to only few genera of microorganisms. The 3-HPA is 116 
subsequently reduced to PDO by at least two 1,3-propanediol oxidoreductases (1,3-PDORs), 117 
including NADH-dependent DhaT (PDOR) and NADPH-dependent hypothetical 118 
oxidoreductase (HOR), along with the regeneration of NAD(P)
+ 
(Fig. 3). E. coli and other 119 
enterobacter sp. have the oxidative (respiratory) pathway of glycerol assimilation. However, 120 
these organisms lack the reductive pathway and cannot grow on glycerol under anaerobic 121 
conditions (Dharmadi et al., 2006; Kumar et al., 2013a).  122 
2.2 Genes and enzymes involved in fermentative metabolism of glycerol 123 
The dha regulon, induced by the DHA molecule and expressed in the absence of 124 
exogenous electron acceptors, encodes numerous genes needed for both the oxidative 125 
(fermentative) and reductive pathways (Celińska, 2012; Forage and Foster, 1982) (Fig. 4A). 126 
The dha regulon of K. pneumoniae contains the following genes arranged in the order as 127 
appears: Kpk_0615/dhaK, dhaM, dhaL, dhaK, dhaD, dhaR, orfW, CdAT, orfX (dhaG), dhaT, 128 
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orfY, dhaB, dhaC, dhaE, orfZ (dhaF), and glpF. Of these, dhaB, dhaC, dhaE, orfX, orfZ, and 129 
dhaT are relatively well documented for their functions in the reductive metabolism of 130 
glycerol. The orfW and orfY genes, although commonly found in the dha regulons of many 131 
organisms, are not as well described. The proteins encoded by the dha regulon of K. 132 
pneumoniae have high similarity (80%–95%) with those of Citrobacter species but not with 133 
those of Clostridium species (30%–80%). Surprisingly, the sequence similarity of dha 134 
proteins among Clostridium species is very low in some cases, even lower than their 135 
similarity to the corresponding proteins in K. pneumoniae or C. freundii (Celińska, 2012; Sun 136 
et al., 2003; Wei et al., 2014). 137 
The complete dha regulon is found in only a few dozen species belonging to five 138 
different taxonomic groups, including four bacterial species [Actinobacteria, Firmicutes, 139 
Fusobacteria, and Proteobacteria (Gammaproteobacteria and Deltaproteobacteria)] and one 140 
archaea species, Halalkalicoccus jeotgali (Martins-Pinheiro et al., 2016). Interestingly, an 141 
incomplete dha regulon is present in more than 100 prokaryotes, suggesting that the enzymes 142 
of the regulon have other functions not restricted to the anaerobic growth on glycerol. A well-143 
documented example is the one found in Lactobacillus species. Lactobacillus cannot grow on 144 
glycerol as the sole carbon source because it lacks the enzymes for oxidative assimilation of 145 
glycerol. However, the enzymes encoded in the incomplete dha regulon enable the 146 
production of PDO from glycerol, which accelerates cell growth in Lactobacillus grown on 147 
glucose (Årsköld et al., 2008; Martins-Pinheiro et al., 2016). 148 
In the following sections, the major enzymes involved in fermentative glycerol 149 
metabolism and their genes are described in detail. 150 
2.2.1 Glycerol dehydrogenase 151 
Encoded by the dhaD and/or gldA gene, glycerol dehydrogenase is an oxidoreductase 152 
that converts glycerol to DHA. The enzyme extracts electrons from glycerol and transfers 153 
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them to NAD
+
. DhaD plays a major role during the anaerobic growth of K. pneumoniae on 154 
glycerol. Quantification of mRNA expression indicates that dhaD is highly induced when 155 
glycerol is used as carbon source. GldA expression is lower than that of DhaD and is thought 156 
to serve as a back up to DhaD during anaerobic growth on glycerol. However, DhaD and 157 
GldA exhibit a high level of similarity in amino acid sequence and have the same substrate-158 
binding site (Wang et al., 2014).  159 
Recently, DhaD was reported to catalyze the interconversion of acetoin and BDO for 160 
NADH disposal and recovery (Wang et al., 2014). The promiscuity of DhaD is responsible 161 
for BDO production in the ΔbudC mutant of K. pneumoniae. The contribution by DhaD to or 162 
its participation in BDO production is also supported by the observed increase in BDO 163 
synthesis and increased concentration of NADH in the presence of the dhaD gene. NADH is 164 
generated by the oxidation of glycerol and consumed by the production of BDO from acetoin. 165 
The dual physiological functions of DhaD allow K. pneumoniae to control the intracellular 166 
redox level. In response to the intracellular level of NADH, DhaD is able to switch its role 167 
from NADH production (glycerol oxidation) to NADH consumption (BDO production) 168 
(Wang et al., 2014). The diversion of glycerol flux from organic acids toward alcohols such 169 
as BDO also helps the cells to counteract intracellular acidification (Petrov and Petrova, 170 
2009). Thus, this promiscuity confers different physiological roles to the enzyme, which 171 
include regulation of the intracellular NADH/NAD
+
 ratio, prevention of acidification, and 172 
storage of carbon and energy (Wang et al., 2014). 173 
2.2.2 Dihydroxyacetone kinases  174 
Dihydroxyacetone kinase (DHAK) phosphorylates DHA to DHAP, an intermediate of 175 
the glycolytic pathway. Sun et al. (2003) analyzed the genome of K. pneumoniae MGH 176 
78578 and found, in addition to ATP-dependent DhaK I, a PEP-dependent DhaK II. DhaK I 177 
is encoded by the dhaK (Kpk_0615) gene, while DhaK II is encoded by three genes, dhaK, 178 
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dhaL and dhaM, which correspond to the medium, small, and large subunits of the enzyme, 179 
respectively (Celińska, 2012; Sun et al., 2003; Wei et al., 2014). The names dhaKLM and 180 
dhaK123 are synonyms used without distinction (Martins-Pinheiro et al., 2016; Sun et al., 181 
2003; Wei et al., 2014). DhaK enzymes are found in many microorganisms. PEP-dependent 182 
DhaK II is present in E. coli, L. lactis, and C. butyricum, whereas ATP-dependent DhaK I is 183 
present in Citrobacter freundii (Garcia-Alles et al., 2004; Raynaud et al., 2011). The PEP-184 
dependent DhaK II of E. coli, encoded by dhaKLM, is homologous to dhaK123 (dhaKLM) of 185 
K. pneumoniae (Gutknecht et al., 2001). In a recent study, Wei et al. (2014) further elucidated 186 
the physiological roles of DhaK I and DhaK II of the dha regulon of K. pneumoniae. They 187 
found that disruption of ATP-dependent DhaK I had no significant effect on glycerol uptake, 188 
indicating that PEP-dependent DhaK II is the major contributor to the conversion of DHA to 189 
DHAP. As in E. coli, the subunits of DhaK II regulate expression of the dha regulon; dha 190 
regulon expression was suppressed by the disruption of dhaK1 (dhaK) and dhaK2 (dhaL). 191 
However, in contrast to E. coli, mutation of dhaK3 (dhaM) in K. pneumonia did not 192 
upregulate the dha regulon but rather decreased cell growth and glycerol uptake.  193 
2.2.3 Glycerol dehydratase and reactivating factor 194 
Glycerol dehydratase (GDHt) is the first enzyme in the reductive pathway and 195 
catalyzes the dehydration of glycerol to 3-HPA. The same reaction can be carried out by diol 196 
dehydratase (DDHt), although the latter has a higher activity on 1,2-propanediol than on 197 
glycerol. GDHt requires coenzyme B12 or S-adenosyl methionine (SAM) as a cofactor. K. 198 
pneumoniae has B12-dependent GDHt only, while strict anaerobes such as clostridia sp. have 199 
SAM-dependent GDHt. The three subunits of GDHt are encoded by the genes dhaB1 (~1670 200 
bp), dhaB2 (~590 bp) and dhaB3 (~430 bp), for which the gene products are the α (large, 201 
60.7 kDa), β (medium, 21.3 kDa), and γ (small, 16.1 kDa) subunits, respectively (Xu et al., 202 
2009a). GDHt of K. pneumoniae is known to be present as a dimer of heterotrimers, (αβγ)2. 203 
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The subunits of GDHt have high homology among K. pneumoniae strains; for example, K. 204 
pneumoniae XJPD-Li and U30909 strains showed >99% identity. 205 
Coenzyme B12 is present in the reaction center and plays an essential role in the 206 
catalysis of GDHt. The catalytic cycle often results in the mechanism-based inactivation of 207 
coenzyme B12 due to the irreversible breakage of the chemical bond between cobalt (Co) and 208 
a carbon of the adenosyl moiety. Oxygen accelerates breakage of the Co–C bond. Oxygen is 209 
also known to inactivate GDHt, even in the absence of the substrate glycerol. The gene 210 
products of orfZ/dhaG (small subunit) and orfX/dhaF (large subunit) act as reactivating 211 
factors of GDHt (GdrAB) (Celińska, 2012; Sun et al., 2003). They reactivate GDHt by 212 
catalyzing the exchange of damaged for intact coenzyme B12 in the presence of ATP and 213 
Mg
2+
/Mn
2+ (Celińska, 2012; Kumar et al., 2013a; Maervoet et al., 2011; Sun et al., 2003; Wei 214 
et al., 2014). The reactivase is a molecular chaperone that functions as a heterotetramer 215 
containing two elongated α subunits (63 kDa) and two globular β subunits (14 kDa). 216 
Structurally, the α subunit resembles both GroEL and Hsp70 chaperones, while the β subunit 217 
resembles that of the β subunit of glycerol dehydratase, except that it lacks some of the amino 218 
acids responsible for coenzyme B12 binding (Liao et al., 2003).  219 
In some organisms, the GDHt enzyme varies in terms of the number of subunits and 220 
their copies (Fig. 4B) (Liu et al., 2010). For example, in Mesorhizobium loti and 221 
Mesorhizobium opportunistum, the large and medium subunits (dhaB1 and dhaB2) are fused 222 
together and encoded by a single gene. The gene fusion may arise by frameshift mutations. 223 
The active site of the fused enzyme differs slightly from that of unfused enzyme. Moreover, 224 
these microorganisms lack the genes encoding the reactivation factor, indicating that the 225 
reactivation process may not exist or is carried out by a different route. Mycobacterium 226 
smegmatis has two subunits (fused dhaB1 + dhaB2 and dhaB3) that are similar to those of M. 227 
loti and M. opportunistum; however, the reactivating factor differs in that it has one (large) 228 
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subunit. No small subunit has been identified in M. smegmatis. Fusobacterium Ilyobacter 229 
polytropus is unique in that it has genes coding for both B12-independent (SAM-dependent) 230 
and B12-dependent GDHt. The genes for B12-independent GDHt are present in the genomic 231 
DNA, while those encoding B12-dependent GDHt along with its reactivation factor are 232 
present in two copies, one in the chromosome and the other in a plasmid. Surprisingly, even 233 
with this gene redundancy, no significant production of 3-HPA and/or PDO has been reported 234 
in I. polytropus (Stieb and Schink, 1984). The B12-independent proteins showed no homology 235 
with B12-dependent GDHt but significant similarity with the pyruvate formate lyases (PFL) 236 
and PFL-activating enzymes and their homologues (Raynaud et al., 2003). 237 
2.2.4 1,3-Propanediol oxidoreductase and hypothetical oxidoreductase 238 
The 1,3-propanediol oxidoreductase (PDOR), responsible for the second step of the 239 
reductive pathway of glycerol, catalyzes the conversion of 3-HPA to PDO with the oxidation 240 
of NAD(P)H. 3-HPA is a toxic intermediate, and PDOR protects the cell from deleterious 241 
damage by reducing 3-HPA to PDO (Celińska, 2012). In K. pneumoniae, PDOR is encoded 242 
by the dhaT gene and is strictly NADH dependent. Active PDOR is a homo-octamer with a 243 
monomeric molecular mass of 43 kDa. Despite its importance, the kinetic properties of DhaT 244 
were elucidated only recently (Lama et al., 2015). DhaT has high specificity for 3-HPA 245 
among various aldehydes. Under physiological conditions at pH 7.0 and 37C, the catalytic 246 
efficiency (kcat/Km) of the forward reaction (3-HPA to PDO) was found to be 77.2/s. mM, 247 
which is 57-fold higher than that of the reverse reaction (1.3/s. mM; PDO to 3-HPA). The Km 248 
(mM) values for 3-HPA and NADH (forward reaction) are 0.77 and 0.03, respectively, while 249 
those for PDO and NAD
+
 (backward reaction) are 7.4 and 0.23, respectively. Furthermore, 250 
the maximum activity of DhaT for the reverse reaction was obtained at pH 9.0 and 55C. 251 
These results strongly suggest that, under physiological conditions, DhaT catalyzes the 252 
reduction of 3-HPA to PDO rather than the oxidation of PDO to 3-HPA. Nevertheless, the 253 
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reverse reaction (PDO→3-HPA) becomes signiﬁcant as the PDO concentration increases. 254 
This factor is considered a serious drawback of using DhaT for PDO production from 255 
glycerol.  256 
K. pneumoniae has several oxidoreductases in addition to PDOR that can reduce 3-257 
HPA to PDO. One such enzyme, designated as hypothetical oxidoreductase (HOR), has been 258 
studied extensively and shares 89% identity with YqhD of E. coli (Zhu et al., 2009; Zhuge et 259 
al., 2010). Expression of yqhD in wild-type K. pneumoniae is not high, with an mRNA level 260 
~20-fold lower than that of dhaT. However, deletion of dhaT increases the transcription of 261 
yqhD by more than 10-fold (Ko et al., 2015). This observation suggests that in addition to its 262 
wide-ranging activity on short-chain aldehydes, YqhD is a detoxification enzyme for many 263 
aldehydes (Jarboe, 2011). YqhD exhibits negligible activity on PDO (backward reaction), 264 
which is an important advantage over DhaT for use in the production of PDO from glycerol 265 
(Celińska, 2012; Chen et al., 2011; Zheng et al., 2006). However, YqhD is kinetically inferior 266 
to DhaT because of its low catalytic activity (kcat/Km) on 3-HPA and the requirement of 267 
NADPH as a cofactor. The kcat/Km value of YqhD on 3-HPA (pH 7.0 and 37C) is estimated 268 
to be 2.1/s. mM, which is 36-fold lower than that of DhaT (unpublished data). The use of 269 
NADPH as a cofactor prohibits this enzyme from being directly coupled to the reactions 270 
catalyzed by DhaD and other enzymes in glycolysis and the TCA cycle, by which NADH is 271 
mainly produced. Furthermore, excessive use of NADPH for PDO production can 272 
significantly reduce the cellular NADPH level and this can disturb many anabolic reactions 273 
requiring NADPH (Wang et al., 2003; Jarboe, 2011). NADH and NADPH differ in a 274 
phosphate group only, and it has been suggested that electrostatic interaction of this 275 
phosphate is the major factor distinguishing NADH from NADPH for enzymes using these 276 
cofactors. Comparison of the amino acid sequences of DhaT and HOR from K. pneumoniae 277 
and YqhD from E. coli has revealed that DhaT contains aspartic acid (Asp) at position 41, 278 
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while HOR and YqhD have valine (Val) at this position. The steric hindrance and 279 
electrostatic repulsion between Asp in the active site and the phosphate group of NADPH 280 
impede their binding. In contrast, the hydrophobic amino acid Val poses no such obstruction; 281 
thus, YqhD uses NADPH as a cofactor (Ma et al., 2010).  282 
Despite their difference in cofactor preference, DhaT and YqhD are similar (44%) in 283 
amino acid sequences. K. pneumoniae has five enzymes that have at least 40% similarity in 284 
amino acid sequence with DhaT and YqhD: putative alcohol dehydrogenase (PaldH), L-1,2-285 
propanediol oxidoreductase (FucO), ethanolamine-utilization enzyme (EutG), propanediol-286 
utilization propanol dehydrogenase (PduQ), and bifunctional alcohol dehydrogenase (AdhE) 287 
(Ko et al., 2015). The roles of these enzymes in PDO production have been investigated. 288 
2.2.5 Regulatory protein 289 
The dhaR gene product is an important transcription factor that is responsible for 290 
expression of the dhaT and dhaB genes (Sun et al., 2003). This gene is found in K. 291 
pneumoniae, C. freundii, and Clostridium botulinum but not in every organism containing a 292 
complete dha regulon (Martins-Pinheiro et al., 2016). The presence of DhaR is thought to 293 
allow the dha operon to function as a separate regulatory system, independent of fumarate 294 
nitrate reduction (FNR). Under anaerobic conditions, FNR acquires DNA-binding properties 295 
and induces the expression of many anaerobiosis-related genes. DhaR contains domains for 296 
GAF (52-199), PAS (203-267), σ54 factor interaction, and histidine HTH-8. The PAS senses 297 
internal levels of energy charge, light, oxygen, and redox potential. The HTH-8 domain has a 298 
helix-turn-helix conformation and acts as a DNA binding structure. The σ54 factor interaction 299 
domain interacts with the σ54 factor of RNA polymerase and activates RNA transcription 300 
from the σ54 promoters (Buck et al., 2000; Taylor and Zhulin, 1999). Thus, the DhaR protein 301 
triggers the transcription of dha genes in response to intracellular levels of several important 302 
physiological parameters (Celińska, 2012; Sun et al., 2003). Zheng et al. (2006) investigated 303 
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the effect of overexpression of the putative regulatory gene dhaR in the dha regulon on 304 
glycerol metabolism in K. pneumoniae. dhaR overexpression increased PDOR activity up to 305 
6.7-fold over that of the control wild-type strain, confirming the role of DhaR as a positive 306 
regulator of the dhaT gene. However, dhaR overexpression did not increase the activity of 307 
glycerol dehydratase (DhaB). Furthermore, despite the significant increase in PDOR activity, 308 
PDO production was unexpectedly low compared with that of the wild type (440 vs. 656.23 309 
mM, respectively). More studies are required to determine the precise role of DhaR and its 310 
regulatory function in the dha regulon.  311 
DhaR in E. coli (70% identity to that of K. pneumoniae) has also been studied. This 312 
protein stimulated transcription of the dhaKLM operon from a σ70 promoter. Interestingly, in 313 
E. coli, DhaL was a positive regulator of the dhaKLM operon while phosphorylated DhaM 314 
and DhaK were negative regulators of the same operon. DhaK contains the DHA-binding site. 315 
DhaL uses ADP as a cofactor for the double displacement of phosphate from DhaM to DHA. 316 
DHA is the oxidation product of glycerol metabolism; binding of DHA to DhaK reduces the 317 
affinity of DhaK for DhaR. In the presence of DHA, DhaL::ATP is dephosphorylated, 318 
leading to the displacement of DhaK by DhaL::ADP, which stimulates DhaR activity. In the 319 
absence of DHA, DhaL::ADP is phosphorylated back to DhaL::ATP by the phototransferase 320 
system (PTS), thereby inhibiting the binding of the phosphorylated complex (DhaL::ATP) to 321 
DhaR. This phosphorylation is mediated by DhaM, providing a phospho-histidine relay 322 
between the PTS and DhaL::ADP. This double-check mechanism of binding and turnover 323 
increases the selectivity such that the binding of nonphosphorylated compounds does not 324 
induce the dha operon (Bächler et al., 2005). 325 
2.3 Genes and enzymes involved in respiratory assimilation of glycerol  326 
The glp regulon comprises the genes encoding proteins required for the conversion of 327 
glycerol to DHAP via sn-glycerol-3-phosphate. The five operons that constitute the glp 328 
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regulon are glpFK, glpD (anaerobic glycerol-3-phosphate dehydrogenase), glp ACB (aerobic 329 
glycerol-3-phosphate dehydrogenase), glpTQ (glycerol-phosphate 330 
permease/glycerophosphodiesterase), and glpEGR. The glpF gene encodes a cytoplasmic 331 
membrane protein that facilitates the diffusion of glycerol into the cell. The glpE gene 332 
encodes an acidic, cytoplasmic protein of 108 amino acids with a molecular weight of 333 
12,082. The glpG gene encodes a basic, cytoplasmic membrane-associated protein of 276 334 
amino acids with a molecular weight of 31,278 (Lin, 1976; Yang and Larson, 1998; Zeng et 335 
al., 1996). The biochemical functions of GlpE and GlpG are unknown. The glpR gene 336 
encodes the GlpR repressor protein. These five operons are located at three different positions 337 
on the chromosome. Transcription of these operons is subject to multiple controls, including 338 
catabolite repression mediated by cAMP-CRP and respiratory control mediated by the FNR 339 
and ArcA/ArcB systems. Moreover, each of the operons is negatively controlled by a 340 
repressor specific for the regulon (Lin, 1987; Zeng et al., 1996). 341 
2.3.1 GlpR and other regulatory proteins 342 
The GlpR repressor protein, predicted to contain 252 amino acids with a molecular 343 
weight of 28,048, belongs to the DeoR bacterial regulatory factor super family. Although not 344 
studied extensively, GlpR of K. pneumonia is expected to have the same biochemical 345 
properties and regulatory functions as that of E. coli. GlpR negatively controls all the glp 346 
operons by binding to operators that overlap or are close to the glp promoters. In case of E. 347 
coli, glycerol-3-phosphate acts as an inducer and has a high affinity for GlpR (Kd = 31 µM) 348 
(Lin, 1987; Weissenborn et al., 1992; Zeng et al., 1996). When complexed with glycerol-3-349 
phosphate, GlpR cannot bind to the operator sites, and repression is relieved. Glycerol-3-350 
phosphate is a product of GlpK and a substrate of GlpD/GlpABC; thus, the absence of GlpD 351 
causes a substantial increase in the level of glycerol-3-phosphate, resulting in induction of the 352 
glp regulon (Fig. 2). The GlpR protein exhibits differential binding affinity for the operators 353 
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of corresponding operons, as follows: glpFK > glpD > glpTQ > glpACB. The glpFK promoter 354 
appears to be the strongest among the glp promoters. Therefore, the maximum strength of the 355 
glpFK promoter combined with the high affinity of GlpK for glycerol (Km = 10 µM) should 356 
result in sufficient accumulation of the inducer, glycerol-3-phosphate, in the presence of 357 
glycerol to relieve repression by GlpR. The relatively lower strength of the glpD promoter 358 
along with the low affinity of the GlpD enzyme for glycerol-3-phosphate (Km = 1 mM) 359 
prevents excessive degradation of glycerol-3-phosphate that is needed for phospholipid 360 
synthesis when the exogenous source of glycerol-3-phosphate becomes limiting, until after 361 
accumulation of the inducer (Lin, 1987; Weissenborn et al., 1992). Recently, Jung et al. 362 
(2014) investigated the role of GlpR in the aerobic production of 3-HP from glycerol in E. 363 
coli. They found that elimination of this regulatory factor caused increased assimilation of 364 
glycerol and higher production of 3-HP and suggested that the deletion of glpR led to the 365 
upregulation of genes involved in glycerol transport and assimilation. K. pneumoniae has 366 
several other regulatory genes in addition to glpR: the global regulatory genes hdeB, hdeD, 367 
and yfdX, with unknown functions and kvgS and kvgA, encoding two proteins comprising a 368 
two-component signal transduction system (Sun et al., 2003). 369 
2.3.2 Glycerol uptake/transport facilitator and other components 370 
The glycerol facilitator GlpF is an integral membrane protein that forms aqueous 371 
pores. The GlpF pores selectively allow passive transport of glycerol and other molecules 372 
such as DHA and urea across the cytoplasmic membrane, but not water or ions (Heller et al., 373 
1980; Reizer et al., 1993). The GlpF protein contains six membrane-spanning helices that are 374 
unique among prokaryotic transport proteins. These transmembrane helices are arranged in 375 
two bundles. The GlpF protein may function as a homodimer with the two six-member 376 
domains arranged in the membrane to form a channel (Weissenborn et al., 1992). K. 377 
pneumoniae has two glycerol transporter genes, one next to orfZ/dhaF in the fermentative 378 
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dha regulon (see Fig. 4A) and the other in the respiratory glpFK operon. Both glpF genes 379 
have a high similarity (85 %) to each other. When one but not both of the glpF genes is 380 
disrupted, the glpF deletion mutants of K. pneumoniae can consume glycerol and convert it to 381 
PDO at a high rate, similar to the wild type (unpublished data; Supplementary Fig. S1). This 382 
observation indicates that both glpF genes encode active glycerol transporter proteins. 383 
However, their presence is not essential for glycerol utilization in K. pneumoniae because the 384 
double-deletion mutant for both facilitators can still uptake glycerol and convert it to PDO. In 385 
E. coli, only one glpF gene is present in the glpFK operon; the GlpF protein shows a high 386 
similarity (80.9%) to that (encoded from glpFK) of K. pneumoniae (Sun et al., 2003). The 387 
importance of GlpF in E. coli also seems to be limited only at low levels of glycerol (<8 388 
mM), as glycerol itself may pass through the membrane by diffusion at high concentrations 389 
(Richey and Lin, 1972).  390 
2.3.3 Simultaneous operation of fermentative and respiratory pathways 391 
The presence of the dha and glp regulons affords K. pneumoniae metabolic flexibility. 392 
The dha regulon enables fermentative utilization of glycerol, while the glp regulon enables 393 
respiratory metabolism of glycerol. During fermentative metabolism of glycerol, redox 394 
constraints force the production of PDO from glycerol, with a low ratio of carbon conversion 395 
yield to cell biomass. Moreover, ATP is formed through substrate-level phosphorylation, and 396 
NADH oxidation occurs through the formation of reduced metabolites. In the presence of 397 
oxygen, the redox constraints forcing the production of PDO are relieved; therefore, the 398 
carbon loss required for regeneration of NAD
+
 is greatly reduced. As a consequence, glycerol 399 
utilization, biomass synthesis, and even the formation of many metabolites increase (Durnin 400 
et al., 2008). Interestingly, the fermentative route (dha regulon) is in operation under a wide 401 
range of oxygen levels, from microaerobic to highly aerobic conditions, as evidenced by 402 
PDO formation. For example, a high titer PDO (102.7 g/L) was produced under the condition 403 
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of 2.0 vvm aeration and even at 3.5 vvm, although the production was a little lowered in the 404 
latter case (Oh et al., 2012a). These results suggest that the fermentative and respiratory 405 
pathways might have evolved to complement each other for optimal control of cell growth 406 
under a wide range of aeration conditions except the strictly anaerobic one.  407 
2.4 Carbon catabolite repression  408 
Carbon catabolite repression (CCR) refers to the suppression of the use of less-409 
preferred carbon sources, when a more preferred carbon, most prominently glucose, is 410 
present. Cyclic AMP, cAMP receptor protein (CRP), and the enzyme EIIA
Glc
, an 411 
intermediate in the phosphorylation cascade of the PTS, are key players in the CCR of 412 
enterobacteria. The EIIA
Glc
, a cytosolic protein, exists in phosphorylated and 413 
unphosphorylated forms. The phosphorylated form stimulates membrane-bound adenylate 414 
cyclase, which catalyzes the formation of cAMP; the cAMP-CRP complex then induces 415 
expression of the catabolic genes of less-preferred carbon sources. The unphosphorylated 416 
form of EIIA
Glc
 is also responsible for inhibiting the transport of less-preferred carbon 417 
sources by inhibitory binding to permeases, causing so-called inducer exclusion (Eppler and 418 
Boos, 1999; Eppler et al., 2002). Glycerol assimilation in K. pneumoniae is greatly inhibited 419 
by CCR in the presence of glucose. This repression is related to not only low cAMP and 420 
cAMP-CRP but also inhibition of GlpK (which functions mainly under aerobic conditions) 421 
by fructose 1,6-bisphosphate, a metabolite produced from glucose. The unphosphorylated 422 
EIIA
Glc
 is also known to allosterically inhibit GlpK (Holtman et al., 2001). Anaerobic 423 
glycerol metabolism mediated by the dha operons is also suppressed by the presence of 424 
glucose. Enzyme-level inhibition similar to that of the aerobic GlpK has not been reported, 425 
but we have observed that, in K. pneumoniae, transcription of the dha operons is greatly 426 
reduced in the presence of glucose (Suman et al., 2017).  427 
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Interestingly, glycerol exerts catabolite repression on the assimilation of maltose in E. 428 
coli. To exert catabolite repression, glycerol must be phosphorylated to glycerol-3-phosphate 429 
(Hogema et al., 1998; Eppler et al. 2002). However, unlike other carbon sources, further 430 
metabolism of glycerol is not required. According to Eppler and Boos (1999), glycerol-3-431 
phosphate reduces expression of MalT, a positive activator of all mal genes. The key players 432 
in this repression are adenylate cyclase, EIIA
Glc
, and CRP. The growth on maltose of the 433 
mutants lacking EIIA
Glc
 or containing truncated adenylate cyclase was no longer repressed by 434 
glycerol, and CRP-independent transcription of malT was also not influenced by glycerol 435 
either. In addition, stimulation of adenylate cyclase by phosphorylated EIIA
Glc
 was controlled 436 
by glycerol-3-phosphate. The mutation in adenylate cyclase relieved the repression caused by 437 
glycerol-3-phosphate (Eppler et al., 2002). Although not investigated, we assume that the 438 
glycerol repression on maltose catabolism also hold true in K. pneumoniae.  439 
Glycerol also exerts catabolite repression on the assimilation of citrate in K. 440 
pneumoniae. Citrate can be used as the sole carbon and energy source during anaerobic 441 
growth of K. pneumoniae, but the presence of glycerol suppresses the expression of the 442 
citrate fermentation genes. A reduced concentration of the cAMP–CRP complex has been 443 
postulated to be the cause of this repression (Meyer et al., 2001). Further research is needed 444 
to test the hypothesis. 445 
3. K. pneumoniae as a microbial cell factory for the production of commodity chemicals 446 
During glycerol fermentation, K. pneumoniae produces many metabolites, including 447 
PDO, BDO, and lactic acid. This section describes the biotechnological production of bulk 448 
chemicals from glycerol in K. pneumoniae. 3-HP is not a natural product during the growth 449 
of K. pneumoniae on glycerol. However, its production is possible using a minor 450 
modification of the PDO synthetic pathway and is included here. The biochemical pathways 451 
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used for the synthesis of these chemicals are explained, and the metabolic engineering used to 452 
improve their production is discussed.  453 
3.1 1,3-Propanediol 454 
PDO, also known as trimethylene glycol, is a promising platform chemical that has 455 
two hydroxyl groups. With terephthalic acid, it can be co-polymerized to the novel co-456 
polymer polytrimethylene terephthalate (PTT). PDO also has applications in the food and 457 
cosmetic industries. Currently, commercial PDO is mainly produced by recombinant E. coli 458 
(Maervoet et al., 2011; Saxena et al., 2009). The global demand for PDO was 60.2 kilotons in 459 
2012 and is predicted to reach approximately 150 kilotons by 2019. The market for PDO is 460 
growing rapidly, from $157 million in 2012 with projections up to $560 million in 2019 461 
(MarketsANDMarkets, 2012; Lee et al., 2015).  462 
K. pneumoniae is one of the best native producers of PDO from glycerol. GDHt and 463 
PDOR are two important enzymes for the conversion of glycerol to PDO (Fig. 3). 464 
Physiologically, the synthesis of PDO from glycerol is essential for the anaerobic growth of 465 
K. pneumoniae, as described previously. The production of PDO requires two cofactors, 466 
coenzyme B12 and NAD(P)H. K. pneumoniae has a de novo pathway for the biosynthesis of 467 
coenzyme B12 that comprises more than 20 genes. NAD(P)H is generated through the 468 
oxidative metabolism of glycerol, during the production of cell biomass and/or oxidized 469 
(pyruvate and acetate) or partially reduced (BDO, lactic acid) metabolites. The production 470 
yield of PDO from glycerol varies depending on the cost of carbon for NAD(P)H production; 471 
the lower the cost, the higher the yield of PDO from glycerol. NADPH can also be the 472 
electron donor for the conversion of 3-HPA to PDO when YqhD is present. However, the 473 
contribution of NADPH to PDO production in native K. pneumoniae seems to be limited 474 
because the PP pathway, which is the main source of NADPH, is not active when glycerol is 475 
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the sole carbon source. Furthermore, K. pneumoniae has very low transhydrogenase activity 476 
for the conversion of NADH to NADPH (Zhang and Xiu, 2009; Chen et al., 2011).  477 
Several metabolic engineering strategies have been employed to improve PDO 478 
production by K. pneumonia (Table 2). Amplification of the reductive pathway by 479 
overexpressing DhaB, PDOR, or both has been attempted by many research groups. As 480 
indicated previously, 3-HPA is highly toxic, and its accumulation is detrimental to cell 481 
viability and toxic to PDO production. To reduce 3-HPA accumulation, overexpression of 482 
dhaT has been attempted. In one study, 3-HPA accumulation was reduced by dhaT 483 
overexpression, but no improvement in PDO production resulted (Hao et al., 2008). 484 
Overexpression of both DhaT and DhaD increased PDO production (56.3%) in batch culture 485 
but no increase in fed-batch culture (Chen et al., 2009). With another K. pneumoniae strain, 486 
DSM 2026, the same experiments were repeated but also with no increase in PDO production 487 
(Zheng et al., 2006). These results suggest that the reductive pathway in K. pneumoniae is 488 
evolutionarily well established (perhaps in concert with the oxidative pathway) and that PDO 489 
production is not limited by expression of the dhaB and dhaT genes of the reductive pathway. 490 
However, in one study where the E. coli yqhD gene was highly overexpressed to give ~10-491 
fold higher PDOR activity (110 IU/mg total protein), a significant increase in PDO titer (25%; 492 
67.6 g/L) and yield (from 0.53 to 0.62 mol/mol), along with less 3-HPA accumulation, was 493 
achieved (Zhu et al., 2009). This observation suggests that in the recombinant strain, NADPH 494 
can play an important role as a cofactor and that PDO production can be increased by 495 
modifying the reductive pathway. It is also probable that the effect of DhaB and PDOR on 496 
PDO production is highly dependent on the strain and/or culture conditions adopted. 497 
Lactic acid, BDO, ethanol, and acetic acid are the major byproducts of PDO synthesis 498 
in K. pneumoniae. Inactivation of the metabolic pathways that give rise to these products has 499 
resulted in increased PDO synthesis. In particular, deletion of the ldhA gene encoding lactate 500 
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dehydrogenase has been highly beneficial. For example, by disrupting the ldhA gene, Xu et al. 501 
(2009b) significantly increased PDO production without lactic acid production. They 502 
observed increases in the PDO titer (95.4–102.1 g/L), conversion yield (0.48–0.52 mol/mol), 503 
and productivity (1.98–2.13 g/L h; Table 2). Similarly, Oh et al. (2012a) achieved the high 504 
PDO titer of 102.7 g/L by deleting ldhA in their own K. pneumoniae isolate. When lactic acid 505 
production was eliminated, more ethanol and succinic acid were generated from the pyruvate 506 
node. Reduction of these compounds has also been attempted by deleting adhE (encoding 507 
alcohol dehydrogenase) and frdA (encoding fumarate reductase). Although the production of 508 
ethanol and succinate was substantially reduced in the triple mutant (∆ldhA∆adhE∆frdA), 509 
PDO production was only marginally increased compared with that of the single ∆ldhA 510 
mutant. The failure of the triple mutant (∆ldhA∆adhE∆frdA) to increase PDO production was 511 
mainly due to an increase in BDO production. Disruption of the BDO pathway encoded by 512 
the bud operon (budA, budB, and budC) has also been studied (Fig. 5). Although partially 513 
effective, individual inactivation of each of the three genes did not successfully decrease 514 
BDO production (Oh et al., 2012a; Wu et al., 2013). Deletion of the entire bud operon 515 
completely eliminated BDO synthesis (Kumar et al., 2016), but seriously hampered cell 516 
growth and glycerol consumption. Consequently, no increase in PDO production was resulted. 517 
Wu et al. (2013) attempted to decrease BDO production while increasing PDO production by 518 
inserting the fdh gene from Candida boidinii (NADH-forming formate dehydrogenase) into 519 
the budC locus. This protocol increased the PDO titer (62.3–72.2 g/L) and yield (0.47–0.57 520 
mol/mol) and decreased the production of BDO by 52.2% and formic acid by 73.4%.  521 
Acetic acid is one of the most toxic metabolites, accumulating in large quantities 522 
during glycerol fermentation by K. pneumonaie (Celińska, 2012). The toxic effects of acetate 523 
is realized even at the low concentration of 20 mM. Physiologically, acetate is a preferred 524 
metabolite for many Enterobacter sp. because its production is accompanied by ATP 525 
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generation. In a typical bioreactor run for PDO production by K. pneumoniae, the 526 
accumulation of acetic acid to >300 mM by the end is not uncommon, which often 527 
completely stops glycerol fermentation. Acetate is produced by Pta-Ack and PoxB when 528 
pyruvate formation is faster than its consumption, which is so-called ‘overflow metabolism’ 529 
(Fig. 6) (De Mey et al., 2007). In K. pneumoniae, the contribution of the poxB gene is not 530 
significant and its deletion does not much affect acetate production. In comparison, deletion 531 
of the pta-ack genes greatly reduces cell growth and results in high accumulation of pyruvate 532 
and pyruvate-based metabolites (Ko et al., 2017). Extensive studies to reduce or eliminate 533 
acetate production have been conducted in E. coli. Compared to poxB, ackA and/or pta were 534 
much more significant in reducing acetate production. However, deletion of the latter genes 535 
was not beneficial because the glycolytic flux and cell yield were seriously reduced and the 536 
accumulation of other byproducts such as pyruvate, lactate, and formate was greatly 537 
increased (Causey et al., 2004; De Mey et al., 2007). Several indirect approaches to 538 
decreasing pyruvate/acetate accumulation were investigated: stimulation of the anaplerotic 539 
pathway by overexpression of pyruvate carboxylase, PEP carboxylase, or PEP carboxykinase 540 
(Abdel-Hamid et al., 2001; Causey et al., 2004; Chao and Liao, 1993; Sanchez et al., 2005); 541 
overexpression of acetyl-CoA synthetase (ACS); increase of the TCA cycle throughput by 542 
deleting the transcriptional repressor arcA gene; and stimulation of the glyoxylate shunt by 543 
deleting the transcriptional repressor iclR gene (De Mey et al., 2007; Jeong et al., 2004; Lin et 544 
al., 2006). Moreover, the use of a mutant pyruvate dehydrogenase which is less sensitive to 545 
inhibition by NADH has also been examined (Kim et al., 2008). In E. coli, these approaches 546 
proved to be effective to varying extents under properly selected culture conditions. However, 547 
they have not yet been fully investigated in K. pneumoniae.  548 
To eliminate byproduct formation, reduction of glycerol flux through the oxidative 549 
pathway at the glycerol node has also been attempted. The deletion of glycerol 550 
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dehydrogenase (dhaD) and/or dihydroxyacetone kinase (dhaK) resulted in decrease of the 551 
oxidative flux and increase of the conversion yield of glycerol to PDO. In addition, 552 
production of the byproducts lactate, ethanol, and succinate but not acetate decreased 553 
significantly, even without blocking the pathways leading to these byproducts (Seo et al. 554 
2009; Horng et al. 2010). However, cell growth and glycerol consumption rate were also 555 
reduced. Interestingly, in these mutant strains, deletion of dhaT has almost no effect on PDO 556 
production. In the absence of dhaT, expression of an HOR, highly homologous to YqhD, was 557 
upregulated (see section 2.2.4).  558 
The theoretical maximum yields of PDO on glycerol are 0.875 and 0.844 mol/mol 559 
under aerobic and anaerobic conditions, respectively (Celińska, 2012). However, 560 
experimentally, the yields are reported between 0.35 and 0.65 mol/mol (Saxena et al., 2009; 561 
Sun et al., 2008). The low yield is mainly attributed to the accumulation of unnecessary 562 
byproducts and inefficient metabolism for generating reducing equivalents (NADH) and ATP. 563 
If acetyl-CoA is fully oxidized through the TCA cycle (without byproducts formation) and 564 
the activity of the electron transport chain (ETC) oxidizing NADH is properly controlled, a 565 
significant increase in PDO yield is expected. Attaining this goal requires extensive pathway 566 
engineering of cellular metabolism. In bioreactor operation, the aeration rate should be 567 
optimized. Oxygen regulates gene expression and the enzymatic reactions of glycerol 568 
metabolism and determines the diversion of DHA to the PP pathway. Regeneration of NADH 569 
by the TCA cycle and its oxidation by ETC are also controlled by oxygen levels. 570 
3.2 3-Hydroxypropionic acid 571 
As with PDO, 3-HP is an important platform chemical and has been selected by the 572 
US Department of Energy (DOE) as one of the top 12 chemicals obtainable from biomass. 3-573 
HP is a C3 bifunctional molecule and a structural isomer of lactic acid (Werpy and Petersen, 574 
2004). 3-HP can be converted into a variety of useful chemicals such as acrylic acid and acryl 575 
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amide (Pina et al., 2011; Kumar et al., 2013a). 3-HP can be synthesized by chemical routes 576 
from acrylic acid, 3-propiolactone, 3-hydroxypropionitrile, allyl alcohol, vinyl acetate, and 577 
PDO. However, none of the chemical processes is commercially feasible at present due to the 578 
high cost of the starting materials, toxicity of intermediates, and/or the environmental 579 
incompatibility of the processes (Jiang et al., 2009; Pina et al., 2011; Kumar et al., 2013a). 580 
Many microorganisms, including both prokaryotes and eukaryotes, can naturally synthesize 581 
3-HP as either an intermediate or end product through a range of metabolic pathways. 582 
However, the production of 3-HP by these native microorganisms is too low to be 583 
commercially meaningful (Jiang et al., 2009; Kumar et al., 2013a).  584 
In studies pursuing commercial production of 3-HP, glycerol is first converted to 3-585 
HPA by GDHt. 3-HPA then is converted to 3-HP via the coenzyme A (CoA)-dependent or 586 
CoA-independent pathway (Fig. 3). In the CoA-independent pathway, 3-HPA is oxidized to 587 
3-HP by aldehyde dehydrogenase (ALDH); in the CoA-dependent pathway, 3-HPA is 588 
converted to 3-HP via 3-HP-CoA and 3-HP-phosphate. In K. pneumoniae, both the CoA-589 
dependent and CoA-independent pathways are present. However, the titer of 3-HP produced 590 
by the CoA-dependent pathway is low as <5.0 g/L (Luo et al., 2011 and 2012). High 591 
production of 3-HP requires the disruption of oxidoreductases (e.g., DhaT, YqhD) and the 592 
overexpression of a proper aldehyde dehydrogenase (ALDH). Ashok et al. (2013a) developed 593 
a recombinant K. pneumoniae in which dhaT and yqhD were deleted, and the homologous 594 
puuC gene encoding the NAD
+
-dependent -glutamyl--aminobutyraldehyde dehydrogenase 595 
was overexpressed. The recombinant K. pneumoniae produced 3.8 g/L 3-HP in 12 h of flask 596 
culture, but only under appropriate aeration (i.e., microaerobic) conditions. Under anaerobic 597 
conditions, PDO (instead of 3-HP) was obtained as the main product, even though two 598 
oxidoreductases were disrupted and puuC was highly overexpressed. In contrast, highly 599 
aerobic conditions produced a high cell mass without much accumulation of either 3-HP or 600 
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1,3-PDO. In a glycerol-fed batch bioreactor experiment under a constant dissolved oxygen 601 
(DO) concentration of 5% (considered “proper” microaerobic condition), the recombinant K. 602 
pneumoniae ΔdhaT ΔyqhD overexpressing both PuuC and DhaB produced >28 g/L 3-HP in 603 
48 h, with a yield of >40%. In contrast, the same strain produced only 10.5 g/L 3-HP when 604 
cultivated under the higher 10% DO conditions. Several important conclusions regarding 3-605 
HP production by K. pneumoniae were made, as follows. First, in addition to DhaT and 606 
YqhD, K. pneumoniae has more unidentified oxidoreductases that can produce PDO from 3-607 
HPA. Second, to produce 3-HP rather than PDO, proper aeration to regenerate NAD
+
 is 608 
essential. Third, excessively high aeration decreases the expression of the Dha regulon and 609 
synthesis of coenzyme B12, an essential cofactor for GDHt catalysis.  610 
To eliminate PDO production even under limited aeration conditions, Ko et al. 611 
attempted to identify and disrupt other potential PDORs from K. pneumoniae (Ko et al., 612 
2015). A mutant strain devoid of dhaT, yqhD, ahpF, and adhE genes was developed; 613 
however, the mutant neither eliminated 1,3-PDO production nor increased 3-HP production. 614 
Again, this result suggests that K. pneumoniae has more unidentified oxidoreductases, and 615 
thus, the complete elimination of 1,3-PDO production during 3-HP production is highly 616 
challenging. To address the important problem, of NAD
+
 regeneration and coenzyme B12 617 
production, Ashok et al. (2013b) studied anaerobic respiration using nitrate as an external 618 
electron acceptor. They attempted to regenerate NAD
+
 from NADH by nitrate reduction 619 
while maintain anaerobic conditions to synthesize and stabilize the oxygen-sensitive 620 
coenzyme B12. Disruption of the glpK gene (encoding for glycerol kinase) was also necessary 621 
because with glpK intact, the rate of anaerobic respiration was too fast, and most of the 622 
glycerol was metabolized through GlpK to produce biomass, as in the case of highly aerobic 623 
cultivation. The anaerobic glycerol fermentation in the presence of nitrate was successful: 624 
1.74 g/L 3-HP was obtained from a 12-h flask culture and 22 g/L 3-HP was produced in a 48-625 
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h fed-batch bioreactor culture (Ashok et al., 2013b) (Table 3). However, disadvantages were 626 
noted, including the requirement for large amounts of nitrate and the toxic effect of nitrite 627 
generated as a reduced intermediate of nitrate. In a recent study, Li et al. (2016) optimized a 628 
promoter for ALDH expression, culture conditions, and metabolic flux to achieve high-level 629 
production of 3-HP in their K. pneumoniae isolate. One recombinant strain, K. pneumoniae 630 
(pTAC-puuC) expressing puuC under the IPTG-inducible tac promoter, produced 73.4 g/L 3-631 
HP in a bioreactor with a molar yield of glycerol of 0.52 and productivity of 1.53 g/L h. 632 
Further, elimination of the ldh1, ldh2, and pta genes elevated the titer and molar yield to 83.8 633 
g/L 3-HP and 0.54 mol/mol, respectively, with decreased cell growth and productivity. This 634 
titer of 3-HP is the highest produced by K. pneumoniae to date. 635 
As another approach to addressing the problem associated with NAD
+
 regeneration 636 
and coenzyme B12 synthesis in 3-HP production, co-production of 3-HP and PDO has been 637 
investigated. The simultaneous production of 3-HP and PDO can eliminate the dependency 638 
on oxidative metabolism of glycerol (and electron transport chain), as the cofactor required 639 
for 3-HP production is regenerated by PDO production or vice versa. Furthermore, the 640 
problems associated with the expression of genes for the assimilation of vitamin B12 and 641 
glycerol can be alleviated substantially because co-production can be performed under 642 
anaerobic or microaerobic conditions (Kumar et al., 2012, 2013b). Ashok et al. (2011) 643 
developed a recombinant strain of K. pneumoniae DSMZ by overexpressing ALDH and 644 
deleting dhaT. With dhaT intact, PDOR activity was too high compared with that of ALDH, 645 
even with overexpression of the latter enzyme from a multicopy plasmid. The recombinant K. 646 
pneumoniae DSMZ accumulated 16.0 g/L 3-HP and 16.8 g/L PDO in 24 h, and the 647 
cumulative yield of these two metabolites on glycerol was 51% (Table 3). Huang et al. (2012) 648 
studied the same co-production using their K. pneumoniae isolate overexpressing ALDH and 649 
obtained 24.4 3-HP and 49.9 g/L PDO, respectively, after 24 h under anaerobic conditions. 650 
28 
 
The cumulative molar yield of the two metabolites reached 0.61 (0.18 for 3-HP and 0.43 for 651 
PDO). In a following study, they showed that the maximum titer of 48.9 g/L 3-HP (along 652 
with 25.3 g/L PDO) was achieved at 1.5 vvm, while the highest concentration of 38.4 g/L 653 
PDO (along with 16.6 g/L 3-HP) was obtained at 0.1 vvm (Huang et al., 2013a).  654 
During 3-HP production from glycerol by K. pneumoniae, the accumulation of such 655 
byproducts as lactic acid, ethanol, acetic acid, formic acid, and 2,3-BDO is a serious 656 
consideration, as in the case of 1,3-PDO production (Ashok et al., 2013a,b; Li et al., 2016). 657 
Deletion of ldhA reduces lactic acid formation and increases the 3-HP yield. However, 658 
deletion of other genes such as adhE, pfl, budBAC, and pta-ack had little desired effect and 659 
seriously hampered cell growth and glycerol assimilation (unpublished data). Even with the 660 
co-production of 3-HP and 1,3-PDO, where oxidative glycerol assimilation was greatly 661 
reduced, accumulation of these byproducts was a serious drawback (Ko et al., 2017). To 662 
prevent the formation of lactic acid along with other byproducts, Kumar et al. (2013b) 663 
employed resting cells of recombinant K. pneumoniae J2B overexpressing ALDH and devoid 664 
of lactate dehydrogenase (ldhA). For this strain, final titers of 3-HP and PDO of 22.7 and 23.5 665 
g/L, respectively, were obtained without lactic acid accumulation. The cumulative product 666 
yield increased to 0.77.  667 
In addition to K. pneumoniae, E. coli has been extensively studied for 3-HP 668 
production from glycerol. Several successful results have been reported by Samsung Ltd. Co. 669 
Korea. One study (Chu et al., 2015) used an engineered strain (E. coli W3110 ΔackA-pta 670 
ΔyqhD_dhaB_mutant gabD4) harboring an active ALDH mutant (designated as GabD4) from 671 
Cupriavidus necator, producing 71.9 g/L 3-HP with a productivity of 1.8 g/L h. However, 672 
unlike K. pneumoniae, E. coli does not synthesize vitamin B12 naturally, and it was necessary 673 
to add the coenzyme externally. Furthermore, a significant amount of glucose for cell growth 674 
was required because for E. coli, glycerol is a less-preferred carbon source than glucose. 675 
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Consequently, the researchers at Samsung initially grew cells to a high density (40–300 676 
OD600) on glucose and then produced 3-HP by feeding glycerol (Chu et al., 2015; Kim et al., 677 
2014a). In comparison, K. pneumoniae can produce a high concentration of 3-HP growing 678 
purely on glycerol at a much lower cell concentration (OD600, <20) (Huang et al., 2013a,b; Li 679 
et al., 2016). Together, the use of glucose for cell proliferation, exogenous addition of 680 
expensive cofactor vitamin B12, and low cumulative yield of 3-HP (on glucose plus glycerol) 681 
increase the production cost. Thus, K. pneumoniae can be considered a better biocatalyst than 682 
E. coli. However, for the commercial production of 3-HP, many other factors are important, 683 
including biosafety, process stability, and downstream processing. Further studies to assess 684 
the potential of these strains as hosts for 3-HP production are needed.  685 
3.3 2,3-Butanediol 686 
BDO has many applications in the pharmaceutical, biomedical, and other chemical 687 
industries for the production of printing inks, perfumes, fumigants, spandex, moistening and 688 
softening agents, and plasticizers (e.g., cellulose nitrate, polyvinyl chloride, polyacrylates) 689 
(Celińska and Grajek, 2009; Ji et al., 2011). BDO can also be used as an antifreezing agent 690 
and octane booster for petrol as is or can be converted to useful derivatives such as 1,3-691 
butadiene, and diacetyl and methyl ethyl ketone. 692 
Unlike 3-HP and PDO, BDO is a product of oxidative metabolism. Of the three 693 
stereoisomers of BDO, K. pneumoniae mainly produces the meso form (Ji et al., 2011). BDO 694 
is synthesized from pyruvate via α-acetolactate and acetoin. The C5 intermediate, α-695 
acetolactate, is formed from two molecules of pyruvate by self-condensation catalyzed by α-696 
acetolactate synthase (ALS; budB). α-Acetolactate is decarboxylated to acetoin by α-697 
acetolactate decarboxylase (budA), and acetoin is reduced to BDO by 2,3-butanediol 698 
dehydrogenase/acetoin reductase (budC) using NADH as a reductant. In the presence of 699 
oxygen, α-acetolactate is spontaneously decarboxylated to diacetyl, further reduced to acetoin 700 
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by action of diacetyl reductase, and then reduced to BDO. α-Acetolactate is also the precursor 701 
of branched-chain amino acids (valine, leucine, and isoleucine); thus, elimination of the bud 702 
operon can arrest K. pneumoniae growth when cultured on glycerol minimal medium (Kumar 703 
et al., 2016). In the anaerobic process, one NADH molecule is required for the conversion of 704 
two pyruvates to one BDO, while the aerobic process requires two NADH (Fig. 5). The 705 
enzyme DhaD may also contribute to BDO formation (see Section 2.2.1). In the BDO 706 
pathway itself, the conversion of two pyruvates to BDO regulates or is regulated by the 707 
intracellular NADH/NAD
+
 ratio, similar to other fermentative pathways. Another important 708 
role of the BDO pathway is to reduce intracellular acidification by converting acids to the 709 
neutral metabolite, BDO (Celińska and Grajek, 2009; Ji et al., 2011). 710 
Although BDO is one of the main byproducts of glycerol fermentation by K. 711 
pneumoniae (Petrov and Petrova, 2009; Durgapal et al. 2014), its production from glycerol 712 
has not been studied extensively. In few studies using glycerol as the carbon source, Petrov 713 
and Petrova (2009) focused on the effects of pH and aeration with their K. pneumoniae 714 
isolate G31. BDO production was greatest at alkaline initial pH when tested at a pH range of 715 
5–8. Without pH control a sharp pH drop occurred initially due to the production of organic 716 
acids, and this pH drop triggered the synthesis of BDO, which is considered the only non-717 
inhibitory compound produced by the oxidative metabolism of glycerol. Once neutral pH is 718 
restored with the rising concentration of BDO, catabolism shifted toward the production of 719 
ATP-generating acetic acid. The amount of BDO generated in each cycle (pH drop and 720 
neutralization) was dependent on the extent of the pH drop. In one study, a BDO 721 
concentration of 49.8 g/L was reached when the initial pH was set at 8.0 and no pH control 722 
was given during the rest of fermentation. PDO was the major byproduct (11.6 g/L) (Table 4) 723 
and its production decreased by exclusion of Co
2+
, an essential component of coenzyme B12. 724 
They also found that intensive aeration led to a significant increase in BDO production; an 725 
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increase in aeration rate from 1.1 to 2.2 vvm enhanced the yield from 0.38 to 0.46 mol/mol 726 
and productivity from 0.24 to 0.36 g/L h. BDO production was also increased by forced pH 727 
fluctuations of the culture medium with discrete ∆pH values (1.0, 2.0, and 3.0) at 728 
predetermined time intervals (6, 12, and 24 h). The highest BDO concentration (70.0 g/L) 729 
was produced by increasing the pH by one unit (∆pH = 1.0) every 12 h (Petrov and Petrova, 730 
2010). The mechanism behind the effect of this peculiar pH change on BDO production has 731 
not been elucidated. Although BDO is readily produced from glycerol by K. pneumoniae, the 732 
volumetric productivity is low due to the long fermentation time (generally >150 h). Huang et 733 
al. (2013b) isolated two Klebsiella strains that produce BDO plus acetoin with a total yield of 734 
0.44–0.45 (g/g). One isolate utilized 64.5 g/L glycerol in 78 h and produced 24.9 g/L BDO, 735 
3.9 g/L acetoin, and 3.2 g/L ethanol. Again, the volumetric productivity was not high.  736 
Metabolic engineering efforts with K. pneumoniae to improve BDO production from 737 
glycerol are limited. Using glucose as carbon source, Kim et al. (2014b) reported that 738 
overexpression of the BDO pathway (budA, budB) in the ldhA deficient K. pneumoniae strain 739 
KCTC2242 improved BDO production and resulted in 90 g/L BDO, with a productivity of 740 
2.75 g/L. h. Because both glucose and glycerol are converted through the common 741 
intermediate pyruvate, BDO production from glycerol is also expected to increase by 742 
amplification of the bud operon. Further work with glycerol as carbon source is required to 743 
prove this effect. Recently, co-production of BDO and PDO from glycerol has also been 744 
attempted (Park et al., 2017). In glycerol fermentation, both alcohols always appear 745 
simultaneously and co-production seems to be beneficial for cells to maintain redox balance 746 
during anaerobic growth. Park et al. (2017) found that by using the K. pneumoniae mutant 747 
deficient of ldhA and mdh, 50.1 g/L BDO was produced along with 63.8 g/L PDO in 75 h. 748 
The ratio of the two alcohols varied according to aeration; with increasing aeration, the ratio 749 
of [BDO]/[PDO] increased as observed by Petrov and Petrova (2010). In the 5,000 L pilot-750 
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scale fed-batch fermentation using crude glycerol, they could produce 114 g/L diols (70 g/L 751 
PDO and 44 g/L BDO) with the yield of 0.60 diols/glycerol (g/g) and a productivity of 2.2 752 
g/L. h of diols. If separation is not an issue, co-production of the two diols can be a good 753 
option.  754 
3.4 Lactic acid 755 
Lactic acid has applications in the food, chemical, cosmetic, and pharmaceutical 756 
industries. Lactic acid is a monomer that can be polymerized to yield the biodegradable 757 
plastics polylactic acid (PLA) and poly(3-hydroxybutyrate-co-lactate). Two optical isomers 758 
of lactic acid, D- and L-lactic acid, are produced in racemic mixtures depending on the 759 
chemical route used. Microbial fermentation can yield optically pure isomers. Currently, 760 
nearly all commercial lactic acid comes from microbial fermentation (Abdel-Rahman et al., 761 
2013; Abdel-Rahman and Sonomoto, 2016).  762 
Because of the availability of highly efficient lactic-acid–producing microbes derived 763 
from E. coli, lactic acid bacteria, and even acid-tolerant yeasts (Abdel-Rahman et al., 2013), 764 
K pneumoniae has received little attention as a lactic acid producer. However, as previously 765 
described, lactic acid is a major byproduct of glycerol fermentation by K. pneumoniae, and its 766 
potential as a producer is high. This bacterium contains metabolic pathways for the 767 
production of both L- and D-isomers (Fig. 7). They are synthesized through the pyruvate 768 
and/or methylglyoxal pathways in K. pneumoniae (Ashok et al., 2011). When produced from 769 
pyruvate, lactate dehydrogenase (ldhA) reduces pyruvate using NADH as reductant. In the 770 
methylglyoxal route, DHAP is converted to methylglyoxal, which can be transformed to both 771 
D- and L-lactic acid. For the production of L-lactic acid, methylglyoxal is reduced to L-772 
lactaldehyde, which is subsequently oxidized to L-lactic acid. Using glutathione, D-lactic acid 773 
is obtained through simultaneous aldehyde group oxidation and keto group reduction of 774 
methylglyoxal (Booth et al., 2003; Booth, 2005). The methylglyoxal route has several 775 
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disadvantages. Methylglyoxal is highly toxic, and its accumulation can severely impair other 776 
metabolisms and even lead to cell death. Second, the route is energetically inefficient, with an 777 
ATP yield of −1. The L- or D-lactic acid product can be converted back into pyruvate by 778 
respiratory lactate dehydrogenase (Mazumdar et al., 2010, 2013).  779 
Several studies showing the potential of K. pneumoniae as a lactic acid producer are 780 
available (Table 4). For example, K. pneumoniae DSMZ is reported to accumulate 22.7 g/L 781 
lactic acid in 24 h during co-production of 3-HP and PDO from glycerol. The titer of lactic 782 
acid was more than that of any of the targeted products, and the yield of lactic acid on 783 
glycerol alone was 0.31 (Ashok et al., 2011). Similarly, fed-batch cultivation of K. 784 
pneumoniae BLh-1 under oxygen-limited conditions gave lactic acid as the main product, 785 
outcompeting PDO; 59 g/L lactic acid was produced in 40 h when crude glycerol from 786 
biodiesel synthesis without any purification was used (Rossi et al., 2013). Durgapal et al. 787 
(2014) also found that K. pneumoniae J2B and DSMZ strains produced lactic acid at 37.0 and 788 
47.8 g/L, respectively (Table 4); in both strains, lactic acid levels surpassed those of the target 789 
product PDO. Recently, Feng et al. (2014) engineered K. pneumoniae ATCC25955 by 790 
overexpressing ldhA and deleting dhaT and yqhD (recall that these two genes are mainly 791 
responsible for PDO production). They found that the recombinant produced 142.1 g/L of 792 
optically pure D-lactic acid from glycerol in fed-batch cultivation under microaerobic 793 
conditions (2.5 vvm and 400 rpm). This result is the highest lactic acid concentration 794 
produced from glycerol reported to date. E. coli has also been engineered for the production 795 
of D- and L-lactate from glycerol (Mazumdar et al., 2010, 2013). For diverting glycerol flux 796 
toward L-lactic acid in E. coli, the chromosomal copy of D-lactate dehydrogenase was 797 
replaced with Streptococcus bovis L-lactate dehydrogenase (Mazumdar et al., 2013). 798 
Moreover, gene encoding lldD (respiratory L-lactate dehydrogenase) was inactivated to 799 
prevent the consumption of L-lactic acid, and the methylglyoxal route (∆mgsA) was blocked 800 
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to prevent production of toxic methylglyoxal and formation of racemic mixtures of D- and L-801 
lactic acid (Fig. 7). Furthermore, the respiratory route for glycerol assimilation was 802 
overexpressed (glpK and glpD) to improve the ATP yield of the metabolic pathway through 803 
transfer of electrons from glycerol-3-phosphate to oxygen (i.e., oxidative phosphorylation). 804 
The engineered E. coli strain (∆pflB ∆pta ∆adhE ∆frdA ∆mgsA ∆lldD ∆ldhA::ldhA_glpK-805 
_glpD) produced 50 g/L of L-lactate from 56 g/L of crude glycerol, at a yield 93% of the 806 
theoretical maximum and with high optical (99.9%) and chemical (97%) purity (Mazumdar et 807 
al., 2013). The approaches proven successful in E. coli should be applicable to K. 808 
pneumoniae. These studies, along with the results by Feng et al. (2014), suggest that K. 809 
pneumoniae is a good host for the production of D- and L-isomers of lactic acid, with high 810 
optical purity, from glycerol. 811 
3.5 Ethanol and other metabolites 812 
K. pneumoniae has also been studied for the production of ethanol, succinic acid, 2-813 
ketogluconic acid, catechol, cis,cis-muconic acid and 2-butanol although its potential for such 814 
production has not been fully explored (Cheng et al., 2013; Jung et al., 2015; Oh et al., 2014; 815 
Wang et al. 2015; Wei et al., 2013). Of these chemicals, ethanol production has been 816 
relatively well studied. Ethanol is a renewable energy source and is widely used as a fuel 817 
additive for partial gasoline replacement. Currently, commercial ethanol is produced from the 818 
fermentation of sugar and starch. However, glycerol is one of the cheapest substrates for 819 
ethanol production, estimated as nearly 40% cheaper than sugar-based production (Yazdani 820 
and Gonzalez, 2007). This factor has encouraged the development of microbial strains for 821 
fermentative conversion of glycerol to ethanol. The metabolic route by which ethanol is 822 
synthesized from glycerol is shown in Fig. 6. Oh et al. (2011, 2012b) constructed a mutant 823 
strain of K. pneumoniae (termed GEM167) through -irradiation. PDO synthesis in this 824 
mutant strain was lower than that of wild type (0.2 vs. 7.93 g/L, respectively), while ethanol 825 
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accumulation was higher (8.6 vs. 1.1 g/L, respectively). The mechanism underlying these 826 
changes remains unclear. Introduction of the pyruvate decarboxylase (pdc) and aldehyde 827 
dehydrogenase (adhII) genes into mutant strains lacking lactate dehydrogenase (ldhA) 828 
resulted in the production of 31.0 g/L (673.9 mM) ethanol, with a yield of 0.89 (mol/mol) and 829 
productivity of 1.2 g/L h (Oh et al., 2012b), the highest level of ethanol production from 830 
glycerol reported to date. More extensive studies including estimation of the maximum 831 
achievable titer and microbial tolerance to high-concentration ethanol, both of which are key 832 
factors for commercialization, are required to assess the potential to produce ethanol from 833 
glycerol by the use of K. pneumoniae. 834 
4. Challenges to bioconversion of glycerol using K. pneumoniae as a biocatalyst  835 
The design of microbial cell factories is gaining unprecedented momentum as 836 
metabolic engineering is progressively aided by advances in synthetic biology and multi-837 
omics analyses. Several bio-based chemicals have already been launched successfully in the 838 
marketplace, and others are in the pipeline. For a bulk chemical to be considered for 839 
commercial production, the production process should achieve a product concentration of 100 840 
g/L, carbon yield of 0.50 (g/g), and volumetric productivity of 2.0 g/L/h. The aforementioned 841 
products produced by K. pneumoniae from glycerol are no exception. Challenges to the use 842 
of K. pneumoniae as a microbial cell factory using glycerol as a carbon source are described. 843 
4.1 Pathogenicity 844 
The pathogenicity of K. pneumoniae is one of the major obstacles to its commercial 845 
application. K. pneumoniae is a Bio-safety Level 2 microorganism and causes nosocomial 846 
and urinary tract infections. Moreover, capsulated K. pneumoniae cells are difficult to 847 
separate from culture broth, complicating the downstream processing. The biotechnological 848 
application of this bacterium will require attenuation of its pathogenicity and reduction of 849 
biosafety concerns. K. pneumoniae produces a number of virulence factors that contribute to 850 
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its pathogenicity, including lipopolysaccharide (LPS), capsular antigens, fimbrial adhesins, 851 
siderophores, and O antigens (Albertí et al., 1993; Fang et al., 2004; Podschun and Ullmann 852 
1998). The mechanism by which this bacterium causes disease is still obscure because most 853 
studies have been conducted on a limited number of virulence factors (El Fertas-Aissani et al., 854 
2013).  855 
In the last decade, efforts have been made to overcome the pathogenicity of K. 856 
pneumoniae (Shrivastav et al., 2013), suggesting hope for the generation of nonpathogenic K. 857 
pneumoniae. The two major pathogenic determinants in K. pneumoniae are the capsular 858 
polysaccharides (CPS), which cover the entire bacterial surface, and LPS, expressed on the 859 
outer bacterial membrane. LPS consists of lipid A, a core oligosaccharide, and an O-antigenic 860 
polysaccharide. In a highly virulent strain of K. pneumoniae, mutations in genes involved in 861 
LPS biosynthesis (waaC, waaF, and wabG) resulted in a decrease in bacterial colonization 862 
and virulence (Izquierdo et al., 2003; Jung et al., 2013). Mutant strains devoid of the outer 863 
core LPS were also found to be deficient in the “cell-attached” capsular polysaccharides 864 
covering the bacterial surface. These mutations abolished the highly virulent characteristics 865 
of pathogenic K. pneumoniae when tested in different animal models. Furthermore, these 866 
mutants were more sensitive to several hydrophobic compounds than were wild-type strains. 867 
Reintroduction of the waaC, waaF, and wabG genes into K. pneumoniae rescued the 868 
pathogenic properties, confirming the role of these genes in pathogenicity.  869 
Another important study was conducted by Lin et al. (2012), in which eight highly 870 
conserved residues of the MagA protein (G308, G310, G334, G337, R290, P305, H323, and 871 
N324) encoded by the mucoviscosity-associated gene A (magA) of K. pneumoniae were 872 
subjected to site-directed mutagenesis. The magA gene contributes to the biosynthesis of K1 873 
capsular polysaccharide (CPS), which correlates with pathogenic phenotypes including 874 
mucoviscosity, serum and phagocytosis resistance, and virulence. Alanine substitutions at 875 
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R290A or H323A abolished MagA function, with annihilation of CPS production, serum 876 
resistance, and virulence. Some K. pneumoniae strains showing less pathogenicity were also 877 
isolated. For example, K. pneumoniae strain J2B produced less LPS and demonstrated a high 878 
sensitivity to many antibiotics and lower pathogenicity. Moreover, its biomass was readily 879 
separated from fermentation broth by centrifugation (Arasu et al., 2011). Future studies 880 
should include further engineering of these less pathogenic strains to make them completely 881 
nonpathogenic, followed by careful evaluation of their toxicity. 882 
4.2 Complex glycerol metabolism 883 
Although glycerol metabolism has been extensively studied, the mechanism and 884 
regulation of its gene expression in K. pneumoniae have not been fully elucidated. The 885 
diversity of glycerol metabolism should be a great advantage for K. pneumoniae survival in 886 
different environments and for its biotechnological utilization as well. However, a high level 887 
of complexity poses difficulty in the engineering of a strain to suit our purposes. Metabolic 888 
complexity is likely responsible in part for the fact that, despite serious attempts, the molar 889 
yield of many important products such as PDO and 3-HP is still far below the theoretical 890 
maximum. Efforts based on our current knowledge, such as the overexpression of DhaB, 891 
DhaT, YqhD and AldH and inactivation/deletion of GlpK, DhaD, DhaK and DhaKLM, were 892 
not satisfactory (Maervoet et al. 2011; Kumar et al. 2013a; Kumar et al., 2016). Another 893 
challenge is to understand how the ratio of glycerol distribution between respiratory and 894 
fermentative routes is controlled. Because the KM of glycerol kinase toward glycerol is low, it 895 
has been speculated that a major fraction of glycerol flows through the respiratory route when 896 
oxygen is present. However, some experimental results do not support this hypothesis. For 897 
example, deletion of glpK does not decrease the glycerol flow through the oxidative pathway 898 
in the presence of oxygen (Ashok et al. 2013a). In fact, wild-type and mutant (∆glpK) strains 899 
of K. pneumoniae demonstrate similar cell growth, glycerol consumption, and PDO 900 
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production profiles under (micro)aerobic conditions. These observations suggest the presence 901 
and/or involvement of other kinases.  902 
Another challenging issue for the use of K. pneumoniae is its inefficient TCA cycle 903 
(Cabelli, 1955). Several genes, including isocitrate dehydrognease (icd), fumarase (fumA), 904 
and malate dehydrogenase (mdh), in K. pneumoniae are significantly less transcribed than 905 
those in E. coli (unpublished data). Furthermore, the activity of isocitrate dehydrogenase was 906 
more than sevenfold lower in K. pneumoniae than in E. coli. If the TCA cycle is inefficient, 907 
achieving a high cell density, which is essential for improving the productivity of target 908 
metabolites, is difficult. Moreover, achieving high-yield generation of NADH with little 909 
consumption of glycerol carbon is difficult. Furthermore, the overflow metabolism that 910 
produces highly toxic acetate becomes more serious. These problems have been well 911 
documented in PDO production. In a recent study, Kumar et al. (2016) attempted to increase 912 
PDO production yield by blocking the lactate and BDO pathways, while diverting carbon 913 
flux through the TCA cycle for efficient regeneration of NADH. However, this effort resulted 914 
in the detrimental accumulation of pyruvate, acetate, and ethanol, causing low NADH 915 
regeneration and low PDO production. Neither increased aeration nor the addition of good 916 
nitrogen sources (complex nitrogen sources) alleviated the accumulation of these 917 
intermediates or activated the TCA cycle. Furthermore, the accumulation of pyruvate quickly 918 
terminated glycerol assimilation. K. pneumoniae has a well-established BDO production 919 
pathway that likely compensates for its inefficient TCA cycle, avoiding the overflow 920 
metabolism and carbon traffic at the pyruvate node. If this is the case, co-production of BDO 921 
along with PDO or 3-HP, rather than single production of PDO or 3-HP, should be more 922 
appropriate, which suits the nature of K. pneumoniae. In fact, when BDO and PDO were co-923 
produced, more PDO was generated than during PDO production alone. More studies are 924 
required to gain a better understanding of glycerol metabolism, the slow operation of the 925 
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TCA cycle in K. pneumoniae, and its effect on the selection of target products and/or 926 
development of suitable strains and processes. Otherwise, it will be difficult to exploit this 927 
potential biocatalyst for commercial manufacturing of valuable chemicals. 928 
4.3 Toxicity of intermediate metabolites and end-products 929 
A general but major challenge to the use of microbial cell factories for producing bulk 930 
chemicals is the toxic effect of target products and metabolic intermediates at high 931 
concentrations. In particular, during the production of PDO or 3-HP from glycerol, the highly 932 
toxic intermediate 3-HPA is inevitably generated. Aldehydes generally damage DNA, 933 
inactivate enzymes, and inhibit DNA synthesis. 3-HPA causes irreversible cessation of 934 
metabolic activity and cellular growth, even at very low concentrations of 15–30 mM (Hao et 935 
al., 2008; Zheng et al., 2008). Native K. pneumoniae does not accumulate 3-HPA at toxic 936 
levels during PDO production, but in engineered strains that overexpress DhaB, high 3-HPA 937 
accumulation is often experienced. To avoid 3-HPA accumulation, enzymes that consume 3-938 
HPA, ALDH (for 3-HP production), and PDOR (for PDO production) are expressed at 939 
sufficiently (sometimes excessively) high levels compared with that of DhaB (Lim et al., 940 
2016). Intermediates such as methylglyoxal, DHA, DHAP, and glyceraldehyde-3-phosphate 941 
are also known to be toxic. 942 
Organic acids and alcohols are toxic at high concentrations. Generally, organic acids 943 
are more toxic than their corresponding alcohols because they disturb the intracellular pH and 944 
have anion-specific effects on metabolism (Chun et al., 2014; Warnecke and Gill, 2005). 945 
When accumulated in cell membranes, organic compounds damage membrane integrity and 946 
inhibit the activity of membrane-bound enzymes. In K. pneumoniae, cell growth and glycerol 947 
assimilation are severely inhibited by high concentrations of PDO or 3-HP. Furthermore, 948 
enzymes that play major roles in 3-HP and PDO production, such as DhaB, DhaT, and AldH, 949 
are inhibited by 3-HP and PDO (Kumar et al. 2013b). Furthermore, K. pneumoniae is 950 
40 
 
sensitive to 24 g/L acetic acid, 26 g/L lactic acid, and 17 g/L ethanol under aerobic conditions 951 
and 15, 19, and 26 g/L, respectively, under anaerobic condition (Celińska, 2012; Cheng et al., 952 
2005). The inhibition of pathways by target product(s) and/or unwanted byproducts often 953 
places a limit on the maximum attainable titer of bulk chemicals. 954 
Several studies have reported engineered improvements in microbial tolerance against 955 
biochemicals and biofuels, especially in E. coli. Modifications of exporter proteins, heat 956 
shock proteins, membrane composition, and stress responses have been attempted. Moreover, 957 
in situ recovery of target products has been attempted for hydrophobic targets. Some tolerant 958 
strains have been developed, but unfortunately, without appreciable increases in productivity 959 
(Dunlop, 2011; Dunlop et al., 2011; Jarboe et al., 2011). Such efforts to improve tolerance to 960 
chemicals have not been reported for K. pneumoniae. 961 
4.4 Availability of glycerol 962 
The global market for glycerol is known to be unpredictable and complex. Glycerol in 963 
the current market mainly is from the biodiesel industry, and its supply is directly affected by 964 
the use of biodiesel. In contrast, glycerol demand depends on many industries that use it as 965 
feedstock. Between 2001 and 2011, the price varied significantly, from $0.70/kg to $1.70/kg 966 
for pure glycerol and from $0.04/kg to $0.33/kg for crude glycerol (Ayoub and Abdullah, 967 
2012; Ciriminna et al., 2014; Kong et al., 2016; Quispe et al., 2013). Nevertheless, glycerol 968 
prices, for pure as well as crude, have come down significantly since 2004, when many 969 
biodiesel production plants initiated operation. The countries producing biodiesel in large 970 
quantities (in million liters) include Germany (2900), Brazil (2300), Argentina (2100), France 971 
(2000), USA (1200), Spain (1100), Italy (800), Indonesia (700), and Thailand (600) (Kong et 972 
al., 2016). The Asia-Pacific region overtook Europe as the largest glycerol market in the 973 
world in 2009 and has remained so ever since. Market growth is driven by increases in the 974 
41 
 
uses for glycerol in such sectors as pharmaceuticals, personal hygiene, and food and beverage 975 
production (Quispe et al., 2013).  976 
The production of crude glycerol is expected to reach 6 million tons by 2025 977 
(Ciriminna et al., 2014). At present, the surplus of glycerol from biodiesel and oleochemicals 978 
is assumed to be sufficient to meet these new demands. However, the scenario may change in 979 
the future with rapid growth of glycerol-based industries and a limited supply of crude 980 
glycerol. For example, if 3-HP produced from glycerol were used as a substitute for the 981 
chemical acrylic acid (global production, 5.85 million tons as of 2014), approximately 7 982 
million tons of glycerol/year would be needed. If we include other platform chemicals such 983 
as PDO, BDO, and ethanol, the demand will be even higher, much more than the expected 984 
supply. The growth of glycerol-based biotechnology will eventually be constrained by the 985 
supply and price of crude glycerol as a carbon source. 986 
5. Concluding remarks 987 
Glycerol is an excellent substrate for the production of biochemicals and biofuels. 988 
Although the biodiesel industry has grown rather slowly in recent years, crude glycerol is still 989 
cheap and generated in large quantities. K. pneumoniae has already been successfully 990 
employed for the production of PDO, 3-HP, BDO, lactic acid, and ethanol from glycerol at 991 
industrially attractive levels. Other metabolites such as acetic acid, pyruvic acid, malic acid, 992 
fumaric acid, alanine, n-butanol, 1,2-propanediol, propionic acid, formic acid, and hydrogen 993 
can also be produced from glycerol by K. pneumoniae, although these have not yet been 994 
extensively explored. At present, sugar-based bioprocesses are prevalent, and no bioprocesses 995 
employing K. pneumoniae and glycerol are commercially available. The pathogenicity of K. 996 
pneumoniae and other technical issues are existing challenges to its use. However, 997 
advancements in the fields of metabolic engineering, synthetic biology, systems biology, and 998 
evolutionary engineering will enable us to further exploit the advantageous nature of K. 999 
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pneumoniae as a biocatalyst and glycerol as a carbon source. A better understanding of 1000 
glycerol metabolism in K. pneumoniae and improvements in its performance as a microbial 1001 
cell factory should make this organism an attractive alternative to current sugar-based 1002 
methods for the production of biochemicals and biofuels. 1003 
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Abstract 18 
Klebsiella pneumoniae is a Gram-negative facultative anaerobe that metabolizes 19 
glycerol efficiently under both aerobic and anaerobic conditions. This microbe is considered 20 
an outstanding biocatalyst for transforming glycerol into a variety of value-added products. 21 
Crude glycerol is a cheap carbon source and can be converted by K. pneumoniae into useful 22 
compounds such as lactic acid, 3-hydroxypropionic acid, ethanol, 1,3-propanediol, 2,3-23 
butanediol, and succinic acid. This review summarizes glycerol metabolism in K. 24 
pneumoniae and its potential as a microbial cell factory for the production of commercially 25 
important acids and alcohols. Although many challenges remain, K. pneumoniae is a 26 
promising workhorse when glycerol is used as the carbon source.  27 
Key words: Klebsiella pneumoniae; Glycerol; 3-Hydroxypropionic acid; 1,3-Propanediol; 28 
2,3-Butanediol; Lactic acid; Ethanol  29 
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1. Introduction 30 
Crude glycerol is produced in large quantities as a byproduct of the biodiesel industry. 31 
Global biodiesel production was 22.7 million tons in 2012 and is forecasted to reach 36.9 32 
million tons by 2020. As a result, worldwide production of glycerol climbed from 1 million 33 
tons in 2000 to 3 million tons in 2011 and is expected to reach 6 million tons by 2025 34 
(Ciriminna et al., 2014; OECD, 2011; Katryniok et al., 2013; Sun et al. 2017). A significant 35 
amount of glycerol is also generated during bioethanol fermentation by yeast. The liquid 36 
fraction of the stillage obtained from ethanol separation contains up to 2% glycerol. Another 37 
source of glycerol is industrial waste generated from vegetable oils and animal fats. For 38 
example, the concentration of glycerol in waste streams from the oleochemical industry is 39 
55%–90% (da Silva et al., 2009; Yazdani and Gonzalez, 2007). The increased availability of 40 
glycerol has caused a substantial reduction in its cost. According to a recent report, the price 41 
of crude glycerol is $0.24/kg and that of pure USP grade glycerol is $0.9/kg (Kong et al., 42 
2016). Extensive research has been conducted to investigate ways to utilize this surplus crude 43 
glycerol. The annual number of research articles addressing the use of glycerol has increased 44 
to >7000, doubling in number from the year 2000 to 2007. Numerous chemical conversions 45 
to valuable products have been reported (Ciriminna et al., 2014). 46 
Glycerol can be used for the microbial production of 1,3-propanediol (PDO), ethanol, 47 
2,3-butanediol (BDO), butanol, lactic acid, 3-hydroxypropionic acid (3-HP), and succinic 48 
acid (Fig. 1) (Clomberg and Gonzalez, 2013; Mattam et al., 2013; Yazdani and Gonzalez, 49 
2007). Because of its reduced nature, glycerol generates twice the number of reducing 50 
equivalents per carbon than do traditional carbohydrates (glucose, xylose, and sucrose) when 51 
converted into the glycolytic intermediates phosphoenolpyruvate (PEP) or pyruvate 52 
(Dharmadi et al., 2006). As a consequence, glycerol gives higher yields of reduced 53 
metabolites (e.g., succinate, ethanol, PDO, and butanol) than does glucose (Yazdani and 54 
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Gonzalez, 2007). Table 1 compares the maximum theoretical yield of various metabolites, 55 
ATP, and redox balances between glycerol and glucose.  56 
Despite its great potential as a carbon source, glycerol is not efficiently metabolized 57 
by many microorganisms under anaerobic or oxygen-limited conditions. The ability of K. 58 
pneumoniae to assimilate glycerol under oxygen-limited conditions is outstanding and has 59 
been studied extensively. Several review articles addressing this issue have also been 60 
published (Clomberg and Gonzalez, 2013; Mattam et al., 2013; Yazdani and Gonzalez, 2007), 61 
but the biotechnological potential and physiological aspects of this strain have not been fully 62 
elucidated. This review explores and discusses glycerol metabolism in K. pneumoniae and the 63 
production of value-added chemicals from glycerol. The potential and challenges of using K. 64 
pneumoniae as a microbial cell factory are also discussed. 65 
2. Glycerol metabolism in K. pneumoniae 66 
Many microorganisms can metabolize glycerol in the presence of external electron 67 
acceptors (respiratory metabolism), but relatively few under non-respiratory conditions 68 
(without exogenous electron acceptors). Among the latter, genera including Citrobacter, 69 
Enterobacter, Bacillus, Propionibacterium, Anaerobiospirillum, Klebsiella, Clostridium, and 70 
Lactobacillus are well documented (da Silva et al., 2009; Yazdani and Gonzalez, 2007). 71 
Some Lactobacillus species including L. reuteri, L. brevis, and L. bucheneri convert glycerol 72 
to PDO but only in the presence of a major carbon source for growth. Glycerol does not 73 
support cell growth, limiting its biotechnological applications. In contrast, Clostridium sp. 74 
grow well on glycerol as the sole carbon source. However, the use of Clostridium is limited 75 
by its slow growth and requirement of strict anaerobic conditions. The lack of a convenient 76 
genetic tool box for large-scale metabolic engineering is another serious drawback of 77 
Clostridium (Branduardi et al., 2014; Lütke-Eversloh and Bahl, 2011).  78 
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From a biotechnological standpoint, Klebsiella sp., especially K. pneumoniae, have 79 
many advantages over the aforementioned microbes. They grow on glycerol as the sole 80 
carbon source under both aerobic and anaerobic conditions (Arasu et al., 2011; Kumar et al., 81 
2012). Their growth is fast, typically growing at a rate >0.9/h, even on glycerol minimal 82 
medium (Arasu et al., 2011). They naturally produce coenzyme B12, an essential cofactor for 83 
the synthesis of the commercially important chemicals PDO and 3-HP (Huang et al., 2013a; 84 
Oh et al., 2012a). Furthermore, their evolutionary and biochemical proximity to E. coli allows 85 
for the application of most of gene manipulation methods developed for E. coli without much 86 
modification (Celińska, 2012; Kumar et al., 2013a). 87 
2.1 Overview of glycerol metabolism in K. pneumoniae 88 
In K. pneumoniae, glycerol is metabolized oxidatively and/or reductively (Ashok et 89 
al., 2011, Kumar et al., 2013a). The oxidative pathway provides energy and carbon 90 
constituents for the synthesis of cell biomass, while the reductive pathway reduces glycerol 91 
and regenerates NAD
+
, enabling the oxidative assimilation of glycerol under anaerobic 92 
conditions.  93 
Glycerol oxidation proceeds in either a respiratory or a fermentative manner. 94 
Respiration requires an exogenous electron acceptor such as oxygen, nitrate, or fumarate 95 
(Ashok et al., 2013a,b) and is carried out by enzymes encoded by the glp regulon. During 96 
respiration, glycerol is first phosphorylated by glycerol kinase (glpK) to yield sn-glycerol-3-97 
phosphate using ATP or phosphoenolpyruvate (PEP) as a phosphate donor. Next, sn-98 
glycerol-3-phosphate is oxidized to dihydroxyacetone phosphate (DHAP) with electron 99 
transfer to a quinone molecule, which is linked to the electron transport chain (ETC). This 100 
transformation is catalyzed by glycerol-3-phosphate dehydrogenase, which is expressed 101 
under both aerobic (glpD) and anaerobic (glpABC) conditions. In contrast, fermentation of 102 
glycerol is conducted without a supply of external electron acceptors, and the reactions are 103 
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catalyzed by enzymes encoded by the dha regulon. Here, glycerol is oxidized to 104 
dihydroxyacetone (DHA) by glycerol dehydrogenase (mainly encoded by dhaD) using NAD
+
 105 
as an electron acceptor. DHA then is phosphorylated by dihydroxyacetone kinase, an enzyme 106 
encoded by the ATP-dependent dhaK1/dhaK and/or PEP-dependent 107 
dhaK2/dhaKLM/dhaK123. DHAP obtained from respiration and/or fermentation is channeled 108 
into the glycolytic pathway (Fig. 2). A variety of organic acids and alcohols, including acetic 109 
acid, lactic acid, succinic acid, ethanol, BDO, and formic acid, are produced by the 110 
downstream glycolytic pathway (Ashok et al., 2011; Kumar et al., 2013a).  111 
The anaerobic growth capability of K. pneumoniae using glycerol as a carbon source 112 
is attributed to its well-established reductive metabolism. In the reductive pathway, glycerol 113 
first undergoes a difficult rearrangement reaction catalyzed by glycerol dehydratase (GDHt) 114 
to yield 3-hydroxypropioaldehyde (3-HPA). Catalysis by GDHt requires coenzyme B12, the 115 
de novo synthesis of which is limited to only few genera of microorganisms. The 3-HPA is 116 
subsequently reduced to PDO by at least two 1,3-propanediol oxidoreductases (1,3-PDORs), 117 
including NADH-dependent DhaT (PDOR) and NADPH-dependent hypothetical 118 
oxidoreductase (HOR), along with the regeneration of NAD(P)
+ 
(Fig. 3). E. coli and other 119 
enterobacter sp. have the oxidative (respiratory) pathway of glycerol assimilation. However, 120 
these organisms lack the reductive pathway and cannot grow on glycerol under anaerobic 121 
conditions (Dharmadi et al., 2006; Kumar et al., 2013a).  122 
2.2 Genes and enzymes involved in fermentative metabolism of glycerol 123 
The dha regulon, induced by the DHA molecule and expressed in the absence of 124 
exogenous electron acceptors, encodes numerous genes needed for both the oxidative 125 
(fermentative) and reductive pathways (Celińska, 2012; Forage and Foster, 1982) (Fig. 4A). 126 
The dha regulon of K. pneumoniae contains the following genes arranged in the order as 127 
appears: Kpk_0615/dhaK, dhaM, dhaL, dhaK, dhaD, dhaR, orfW, CdAT, orfX (dhaG), dhaT, 128 
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orfY, dhaB, dhaC, dhaE, orfZ (dhaF), and glpF. Of these, dhaB, dhaC, dhaE, orfX, orfZ, and 129 
dhaT are relatively well documented for their functions in the reductive metabolism of 130 
glycerol. The orfW and orfY genes, although commonly found in the dha regulons of many 131 
organisms, are not as well described. The proteins encoded by the dha regulon of K. 132 
pneumoniae have high similarity (80%–95%) with those of Citrobacter species but not with 133 
those of Clostridium species (30%–80%). Surprisingly, the sequence similarity of dha 134 
proteins among Clostridium species is very low in some cases, even lower than their 135 
similarity to the corresponding proteins in K. pneumoniae or C. freundii (Celińska, 2012; Sun 136 
et al., 2003; Wei et al., 2014). 137 
The complete dha regulon is found in only a few dozen species belonging to five 138 
different taxonomic groups, including four bacterial species [Actinobacteria, Firmicutes, 139 
Fusobacteria, and Proteobacteria (Gammaproteobacteria and Deltaproteobacteria)] and one 140 
archaea species, Halalkalicoccus jeotgali (Martins-Pinheiro et al., 2016). Interestingly, an 141 
incomplete dha regulon is present in more than 100 prokaryotes, suggesting that the enzymes 142 
of the regulon have other functions not restricted to the anaerobic growth on glycerol. A well-143 
documented example is the one found in Lactobacillus species. Lactobacillus cannot grow on 144 
glycerol as the sole carbon source because it lacks the enzymes for oxidative assimilation of 145 
glycerol. However, the enzymes encoded in the incomplete dha regulon enable the 146 
production of PDO from glycerol, which accelerates cell growth in Lactobacillus grown on 147 
glucose (Årsköld et al., 2008; Martins-Pinheiro et al., 2016). 148 
In the following sections, the major enzymes involved in fermentative glycerol 149 
metabolism and their genes are described in detail. 150 
2.2.1 Glycerol dehydrogenase 151 
Encoded by the dhaD and/or gldA gene, glycerol dehydrogenase is an oxidoreductase 152 
that converts glycerol to DHA. The enzyme extracts electrons from glycerol and transfers 153 
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them to NAD
+
. DhaD plays a major role during the anaerobic growth of K. pneumoniae on 154 
glycerol. Quantification of mRNA expression indicates that dhaD is highly induced when 155 
glycerol is used as carbon source. GldA expression is lower than that of DhaD and is thought 156 
to serve as a back up to DhaD during anaerobic growth on glycerol. However, DhaD and 157 
GldA exhibit a high level of similarity in amino acid sequence and have the same substrate-158 
binding site (Wang et al., 2014).  159 
Recently, DhaD was reported to catalyze the interconversion of acetoin and BDO for 160 
NADH disposal and recovery (Wang et al., 2014). The promiscuity of DhaD is responsible 161 
for BDO production in the ΔbudC mutant of K. pneumoniae. The contribution by DhaD to or 162 
its participation in BDO production is also supported by the observed increase in BDO 163 
synthesis and increased concentration of NADH in the presence of the dhaD gene. NADH is 164 
generated by the oxidation of glycerol and consumed by the production of BDO from acetoin. 165 
The dual physiological functions of DhaD allow K. pneumoniae to control the intracellular 166 
redox level. In response to the intracellular level of NADH, DhaD is able to switch its role 167 
from NADH production (glycerol oxidation) to NADH consumption (BDO production) 168 
(Wang et al., 2014). The diversion of glycerol flux from organic acids toward alcohols such 169 
as BDO also helps the cells to counteract intracellular acidification (Petrov and Petrova, 170 
2009). Thus, this promiscuity confers different physiological roles to the enzyme, which 171 
include regulation of the intracellular NADH/NAD
+
 ratio, prevention of acidification, and 172 
storage of carbon and energy (Wang et al., 2014). 173 
2.2.2 Dihydroxyacetone kinases  174 
Dihydroxyacetone kinase (DHAK) phosphorylates DHA to DHAP, an intermediate of 175 
the glycolytic pathway. Sun et al. (2003) analyzed the genome of K. pneumoniae MGH 176 
78578 and found, in addition to ATP-dependent DhaK I, a PEP-dependent DhaK II. DhaK I 177 
is encoded by the dhaK (Kpk_0615) gene, while DhaK II is encoded by three genes, dhaK, 178 
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dhaL and dhaM, which correspond to the medium, small, and large subunits of the enzyme, 179 
respectively (Celińska, 2012; Sun et al., 2003; Wei et al., 2014). The names dhaKLM and 180 
dhaK123 are synonyms used without distinction (Martins-Pinheiro et al., 2016; Sun et al., 181 
2003; Wei et al., 2014). DhaK enzymes are found in many microorganisms. PEP-dependent 182 
DhaK II is present in E. coli, L. lactis, and C. butyricum, whereas ATP-dependent DhaK I is 183 
present in Citrobacter freundii (Garcia-Alles et al., 2004; Raynaud et al., 2011). The PEP-184 
dependent DhaK II of E. coli, encoded by dhaKLM, is homologous to dhaK123 (dhaKLM) of 185 
K. pneumoniae (Gutknecht et al., 2001). In a recent study, Wei et al. (2014) further elucidated 186 
the physiological roles of DhaK I and DhaK II of the dha regulon of K. pneumoniae. They 187 
found that disruption of ATP-dependent DhaK I had no significant effect on glycerol uptake, 188 
indicating that PEP-dependent DhaK II is the major contributor to the conversion of DHA to 189 
DHAP. As in E. coli, the subunits of DhaK II regulate expression of the dha regulon; dha 190 
regulon expression was suppressed by the disruption of dhaK1 (dhaK) and dhaK2 (dhaL). 191 
However, in contrast to E. coli, mutation of dhaK3 (dhaM) in K. pneumonia did not 192 
upregulate the dha regulon but rather decreased cell growth and glycerol uptake.  193 
2.2.3 Glycerol dehydratase and reactivating factor 194 
Glycerol dehydratase (GDHt) is the first enzyme in the reductive pathway and 195 
catalyzes the dehydration of glycerol to 3-HPA. The same reaction can be carried out by diol 196 
dehydratase (DDHt), although the latter has a higher activity on 1,2-propanediol than on 197 
glycerol. GDHt requires coenzyme B12 or S-adenosyl methionine (SAM) as a cofactor. K. 198 
pneumoniae has B12-dependent GDHt only, while strict anaerobes such as clostridia sp. have 199 
SAM-dependent GDHt. The three subunits of GDHt are encoded by the genes dhaB1 (~1670 200 
bp), dhaB2 (~590 bp) and dhaB3 (~430 bp), for which the gene products are the α (large, 201 
60.7 kDa), β (medium, 21.3 kDa), and γ (small, 16.1 kDa) subunits, respectively (Xu et al., 202 
2009a). GDHt of K. pneumoniae is known to be present as a dimer of heterotrimers, (αβγ)2. 203 
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The subunits of GDHt have high homology among K. pneumoniae strains; for example, K. 204 
pneumoniae XJPD-Li and U30909 strains showed >99% identity. 205 
Coenzyme B12 is present in the reaction center and plays an essential role in the 206 
catalysis of GDHt. The catalytic cycle often results in the mechanism-based inactivation of 207 
coenzyme B12 due to the irreversible breakage of the chemical bond between cobalt (Co) and 208 
a carbon of the adenosyl moiety. Oxygen accelerates breakage of the Co–C bond. Oxygen is 209 
also known to inactivate GDHt, even in the absence of the substrate glycerol. The gene 210 
products of orfZ/dhaG (small subunit) and orfX/dhaF (large subunit) act as reactivating 211 
factors of GDHt (GdrAB) (Celińska, 2012; Sun et al., 2003). They reactivate GDHt by 212 
catalyzing the exchange of damaged for intact coenzyme B12 in the presence of ATP and 213 
Mg
2+
/Mn
2+ (Celińska, 2012; Kumar et al., 2013a; Maervoet et al., 2011; Sun et al., 2003; Wei 214 
et al., 2014). The reactivase is a molecular chaperone that functions as a heterotetramer 215 
containing two elongated α subunits (63 kDa) and two globular β subunits (14 kDa). 216 
Structurally, the α subunit resembles both GroEL and Hsp70 chaperones, while the β subunit 217 
resembles that of the β subunit of glycerol dehydratase, except that it lacks some of the amino 218 
acids responsible for coenzyme B12 binding (Liao et al., 2003).  219 
In some organisms, the GDHt enzyme varies in terms of the number of subunits and 220 
their copies (Fig. 4B) (Liu et al., 2010). For example, in Mesorhizobium loti and 221 
Mesorhizobium opportunistum, the large and medium subunits (dhaB1 and dhaB2) are fused 222 
together and encoded by a single gene. The gene fusion may arise by frameshift mutations. 223 
The active site of the fused enzyme differs slightly from that of unfused enzyme. Moreover, 224 
these microorganisms lack the genes encoding the reactivation factor, indicating that the 225 
reactivation process may not exist or is carried out by a different route. Mycobacterium 226 
smegmatis has two subunits (fused dhaB1 + dhaB2 and dhaB3) that are similar to those of M. 227 
loti and M. opportunistum; however, the reactivating factor differs in that it has one (large) 228 
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subunit. No small subunit has been identified in M. smegmatis. Fusobacterium Ilyobacter 229 
polytropus is unique in that it has genes coding for both B12-independent (SAM-dependent) 230 
and B12-dependent GDHt. The genes for B12-independent GDHt are present in the genomic 231 
DNA, while those encoding B12-dependent GDHt along with its reactivation factor are 232 
present in two copies, one in the chromosome and the other in a plasmid. Surprisingly, even 233 
with this gene redundancy, no significant production of 3-HPA and/or PDO has been reported 234 
in I. polytropus (Stieb and Schink, 1984). The B12-independent proteins showed no homology 235 
with B12-dependent GDHt but significant similarity with the pyruvate formate lyases (PFL) 236 
and PFL-activating enzymes and their homologues (Raynaud et al., 2003). 237 
2.2.4 1,3-Propanediol oxidoreductase and hypothetical oxidoreductase 238 
The 1,3-propanediol oxidoreductase (PDOR), responsible for the second step of the 239 
reductive pathway of glycerol, catalyzes the conversion of 3-HPA to PDO with the oxidation 240 
of NAD(P)H. 3-HPA is a toxic intermediate, and PDOR protects the cell from deleterious 241 
damage by reducing 3-HPA to PDO (Celińska, 2012). In K. pneumoniae, PDOR is encoded 242 
by the dhaT gene and is strictly NADH dependent. Active PDOR is a homo-octamer with a 243 
monomeric molecular mass of 43 kDa. Despite its importance, the kinetic properties of DhaT 244 
were elucidated only recently (Lama et al., 2015). DhaT has high specificity for 3-HPA 245 
among various aldehydes. Under physiological conditions at pH 7.0 and 37C, the catalytic 246 
efficiency (kcat/Km) of the forward reaction (3-HPA to PDO) was found to be 77.2/s. mM, 247 
which is 57-fold higher than that of the reverse reaction (1.3/s. mM; PDO to 3-HPA). The Km 248 
(mM) values for 3-HPA and NADH (forward reaction) are 0.77 and 0.03, respectively, while 249 
those for PDO and NAD
+
 (backward reaction) are 7.4 and 0.23, respectively. Furthermore, 250 
the maximum activity of DhaT for the reverse reaction was obtained at pH 9.0 and 55C. 251 
These results strongly suggest that, under physiological conditions, DhaT catalyzes the 252 
reduction of 3-HPA to PDO rather than the oxidation of PDO to 3-HPA. Nevertheless, the 253 
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reverse reaction (PDO→3-HPA) becomes signiﬁcant as the PDO concentration increases. 254 
This factor is considered a serious drawback of using DhaT for PDO production from 255 
glycerol.  256 
K. pneumoniae has several oxidoreductases in addition to PDOR that can reduce 3-257 
HPA to PDO. One such enzyme, designated as hypothetical oxidoreductase (HOR), has been 258 
studied extensively and shares 89% identity with YqhD of E. coli (Zhu et al., 2009; Zhuge et 259 
al., 2010). Expression of yqhD in wild-type K. pneumoniae is not high, with an mRNA level 260 
~20-fold lower than that of dhaT. However, deletion of dhaT increases the transcription of 261 
yqhD by more than 10-fold (Ko et al., 2015). This observation suggests that in addition to its 262 
wide-ranging activity on short-chain aldehydes, YqhD is a detoxification enzyme for many 263 
aldehydes (Jarboe, 2011). YqhD exhibits negligible activity on PDO (backward reaction), 264 
which is an important advantage over DhaT for use in the production of PDO from glycerol 265 
(Celińska, 2012; Chen et al., 2011; Zheng et al., 2006). However, YqhD is kinetically inferior 266 
to DhaT because of its low catalytic activity (kcat/Km) on 3-HPA and the requirement of 267 
NADPH as a cofactor. The kcat/Km value of YqhD on 3-HPA (pH 7.0 and 37C) is estimated 268 
to be 2.1/s. mM, which is 36-fold lower than that of DhaT (unpublished data). The use of 269 
NADPH as a cofactor prohibits this enzyme from being directly coupled to the reactions 270 
catalyzed by DhaD and other enzymes in glycolysis and the TCA cycle, by which NADH is 271 
mainly produced. Furthermore, excessive use of NADPH for PDO production can 272 
significantly reduce the cellular NADPH level and this can disturb many anabolic reactions 273 
requiring NADPH (Wang et al., 2003; Jarboe, 2011). NADH and NADPH differ in a 274 
phosphate group only, and it has been suggested that electrostatic interaction of this 275 
phosphate is the major factor distinguishing NADH from NADPH for enzymes using these 276 
cofactors. Comparison of the amino acid sequences of DhaT and HOR from K. pneumoniae 277 
and YqhD from E. coli has revealed that DhaT contains aspartic acid (Asp) at position 41, 278 
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while HOR and YqhD have valine (Val) at this position. The steric hindrance and 279 
electrostatic repulsion between Asp in the active site and the phosphate group of NADPH 280 
impede their binding. In contrast, the hydrophobic amino acid Val poses no such obstruction; 281 
thus, YqhD uses NADPH as a cofactor (Ma et al., 2010).  282 
Despite their difference in cofactor preference, DhaT and YqhD are similar (44%) in 283 
amino acid sequences. K. pneumoniae has five enzymes that have at least 40% similarity in 284 
amino acid sequence with DhaT and YqhD: putative alcohol dehydrogenase (PaldH), L-1,2-285 
propanediol oxidoreductase (FucO), ethanolamine-utilization enzyme (EutG), propanediol-286 
utilization propanol dehydrogenase (PduQ), and bifunctional alcohol dehydrogenase (AdhE) 287 
(Ko et al., 2015). The roles of these enzymes in PDO production have been investigated. 288 
2.2.5 Regulatory protein 289 
The dhaR gene product is an important transcription factor that is responsible for 290 
expression of the dhaT and dhaB genes (Sun et al., 2003). This gene is found in K. 291 
pneumoniae, C. freundii, and Clostridium botulinum but not in every organism containing a 292 
complete dha regulon (Martins-Pinheiro et al., 2016). The presence of DhaR is thought to 293 
allow the dha operon to function as a separate regulatory system, independent of fumarate 294 
nitrate reduction (FNR). Under anaerobic conditions, FNR acquires DNA-binding properties 295 
and induces the expression of many anaerobiosis-related genes. DhaR contains domains for 296 
GAF (52-199), PAS (203-267), σ54 factor interaction, and histidine HTH-8. The PAS senses 297 
internal levels of energy charge, light, oxygen, and redox potential. The HTH-8 domain has a 298 
helix-turn-helix conformation and acts as a DNA binding structure. The σ54 factor interaction 299 
domain interacts with the σ54 factor of RNA polymerase and activates RNA transcription 300 
from the σ54 promoters (Buck et al., 2000; Taylor and Zhulin, 1999). Thus, the DhaR protein 301 
triggers the transcription of dha genes in response to intracellular levels of several important 302 
physiological parameters (Celińska, 2012; Sun et al., 2003). Zheng et al. (2006) investigated 303 
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the effect of overexpression of the putative regulatory gene dhaR in the dha regulon on 304 
glycerol metabolism in K. pneumoniae. dhaR overexpression increased PDOR activity up to 305 
6.7-fold over that of the control wild-type strain, confirming the role of DhaR as a positive 306 
regulator of the dhaT gene. However, dhaR overexpression did not increase the activity of 307 
glycerol dehydratase (DhaB). Furthermore, despite the significant increase in PDOR activity, 308 
PDO production was unexpectedly low compared with that of the wild type (440 vs. 656.23 309 
mM, respectively). More studies are required to determine the precise role of DhaR and its 310 
regulatory function in the dha regulon.  311 
DhaR in E. coli (70% identity to that of K. pneumoniae) has also been studied. This 312 
protein stimulated transcription of the dhaKLM operon from a σ70 promoter. Interestingly, in 313 
E. coli, DhaL was a positive regulator of the dhaKLM operon while phosphorylated DhaM 314 
and DhaK were negative regulators of the same operon. DhaK contains the DHA-binding site. 315 
DhaL uses ADP as a cofactor for the double displacement of phosphate from DhaM to DHA. 316 
DHA is the oxidation product of glycerol metabolism; binding of DHA to DhaK reduces the 317 
affinity of DhaK for DhaR. In the presence of DHA, DhaL::ATP is dephosphorylated, 318 
leading to the displacement of DhaK by DhaL::ADP, which stimulates DhaR activity. In the 319 
absence of DHA, DhaL::ADP is phosphorylated back to DhaL::ATP by the phototransferase 320 
system (PTS), thereby inhibiting the binding of the phosphorylated complex (DhaL::ATP) to 321 
DhaR. This phosphorylation is mediated by DhaM, providing a phospho-histidine relay 322 
between the PTS and DhaL::ADP. This double-check mechanism of binding and turnover 323 
increases the selectivity such that the binding of nonphosphorylated compounds does not 324 
induce the dha operon (Bächler et al., 2005). 325 
2.3 Genes and enzymes involved in respiratory assimilation of glycerol  326 
The glp regulon comprises the genes encoding proteins required for the conversion of 327 
glycerol to DHAP via sn-glycerol-3-phosphate. The five operons that constitute the glp 328 
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regulon are glpFK, glpD (anaerobic glycerol-3-phosphate dehydrogenase), glp ACB (aerobic 329 
glycerol-3-phosphate dehydrogenase), glpTQ (glycerol-phosphate 330 
permease/glycerophosphodiesterase), and glpEGR. The glpF gene encodes a cytoplasmic 331 
membrane protein that facilitates the diffusion of glycerol into the cell. The glpE gene 332 
encodes an acidic, cytoplasmic protein of 108 amino acids with a molecular weight of 333 
12,082. The glpG gene encodes a basic, cytoplasmic membrane-associated protein of 276 334 
amino acids with a molecular weight of 31,278 (Lin, 1976; Yang and Larson, 1998; Zeng et 335 
al., 1996). The biochemical functions of GlpE and GlpG are unknown. The glpR gene 336 
encodes the GlpR repressor protein. These five operons are located at three different positions 337 
on the chromosome. Transcription of these operons is subject to multiple controls, including 338 
catabolite repression mediated by cAMP-CRP and respiratory control mediated by the FNR 339 
and ArcA/ArcB systems. Moreover, each of the operons is negatively controlled by a 340 
repressor specific for the regulon (Lin, 1987; Zeng et al., 1996). 341 
2.3.1 GlpR and other regulatory proteins 342 
The GlpR repressor protein, predicted to contain 252 amino acids with a molecular 343 
weight of 28,048, belongs to the DeoR bacterial regulatory factor super family. Although not 344 
studied extensively, GlpR of K. pneumonia is expected to have the same biochemical 345 
properties and regulatory functions as that of E. coli. GlpR negatively controls all the glp 346 
operons by binding to operators that overlap or are close to the glp promoters. In case of E. 347 
coli, glycerol-3-phosphate acts as an inducer and has a high affinity for GlpR (Kd = 31 µM) 348 
(Lin, 1987; Weissenborn et al., 1992; Zeng et al., 1996). When complexed with glycerol-3-349 
phosphate, GlpR cannot bind to the operator sites, and repression is relieved. Glycerol-3-350 
phosphate is a product of GlpK and a substrate of GlpD/GlpABC; thus, the absence of GlpD 351 
causes a substantial increase in the level of glycerol-3-phosphate, resulting in induction of the 352 
glp regulon (Fig. 2). The GlpR protein exhibits differential binding affinity for the operators 353 
16 
 
of corresponding operons, as follows: glpFK > glpD > glpTQ > glpACB. The glpFK promoter 354 
appears to be the strongest among the glp promoters. Therefore, the maximum strength of the 355 
glpFK promoter combined with the high affinity of GlpK for glycerol (Km = 10 µM) should 356 
result in sufficient accumulation of the inducer, glycerol-3-phosphate, in the presence of 357 
glycerol to relieve repression by GlpR. The relatively lower strength of the glpD promoter 358 
along with the low affinity of the GlpD enzyme for glycerol-3-phosphate (Km = 1 mM) 359 
prevents excessive degradation of glycerol-3-phosphate that is needed for phospholipid 360 
synthesis when the exogenous source of glycerol-3-phosphate becomes limiting, until after 361 
accumulation of the inducer (Lin, 1987; Weissenborn et al., 1992). Recently, Jung et al. 362 
(2014) investigated the role of GlpR in the aerobic production of 3-HP from glycerol in E. 363 
coli. They found that elimination of this regulatory factor caused increased assimilation of 364 
glycerol and higher production of 3-HP and suggested that the deletion of glpR led to the 365 
upregulation of genes involved in glycerol transport and assimilation. K. pneumoniae has 366 
several other regulatory genes in addition to glpR: the global regulatory genes hdeB, hdeD, 367 
and yfdX, with unknown functions and kvgS and kvgA, encoding two proteins comprising a 368 
two-component signal transduction system (Sun et al., 2003). 369 
2.3.2 Glycerol uptake/transport facilitator and other components 370 
The glycerol facilitator GlpF is an integral membrane protein that forms aqueous 371 
pores. The GlpF pores selectively allow passive transport of glycerol and other molecules 372 
such as DHA and urea across the cytoplasmic membrane, but not water or ions (Heller et al., 373 
1980; Reizer et al., 1993). The GlpF protein contains six membrane-spanning helices that are 374 
unique among prokaryotic transport proteins. These transmembrane helices are arranged in 375 
two bundles. The GlpF protein may function as a homodimer with the two six-member 376 
domains arranged in the membrane to form a channel (Weissenborn et al., 1992). K. 377 
pneumoniae has two glycerol transporter genes, one next to orfZ/dhaF in the fermentative 378 
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dha regulon (see Fig. 4A) and the other in the respiratory glpFK operon. Both glpF genes 379 
have a high similarity (85 %) to each other. When one but not both of the glpF genes is 380 
disrupted, the glpF deletion mutants of K. pneumoniae can consume glycerol and convert it to 381 
PDO at a high rate, similar to the wild type (unpublished data; Supplementary Fig. S1). This 382 
observation indicates that both glpF genes encode active glycerol transporter proteins. 383 
However, their presence is not essential for glycerol utilization in K. pneumoniae because the 384 
double-deletion mutant for both facilitators can still uptake glycerol and convert it to PDO. In 385 
E. coli, only one glpF gene is present in the glpFK operon; the GlpF protein shows a high 386 
similarity (80.9%) to that (encoded from glpFK) of K. pneumoniae (Sun et al., 2003). The 387 
importance of GlpF in E. coli also seems to be limited only at low levels of glycerol (<8 388 
mM), as glycerol itself may pass through the membrane by diffusion at high concentrations 389 
(Richey and Lin, 1972).  390 
2.3.3 Simultaneous operation of fermentative and respiratory pathways 391 
The presence of the dha and glp regulons affords K. pneumoniae metabolic flexibility. 392 
The dha regulon enables fermentative utilization of glycerol, while the glp regulon enables 393 
respiratory metabolism of glycerol. During fermentative metabolism of glycerol, redox 394 
constraints force the production of PDO from glycerol, with a low ratio of carbon conversion 395 
yield to cell biomass. Moreover, ATP is formed through substrate-level phosphorylation, and 396 
NADH oxidation occurs through the formation of reduced metabolites. In the presence of 397 
oxygen, the redox constraints forcing the production of PDO are relieved; therefore, the 398 
carbon loss required for regeneration of NAD
+
 is greatly reduced. As a consequence, glycerol 399 
utilization, biomass synthesis, and even the formation of many metabolites increase (Durnin 400 
et al., 2008). Interestingly, the fermentative route (dha regulon) is in operation under a wide 401 
range of oxygen levels, from microaerobic to highly aerobic conditions, as evidenced by 402 
PDO formation. For example, a high titer PDO (102.7 g/L) was produced under the condition 403 
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of 2.0 vvm aeration and even at 3.5 vvm, although the production was a little lowered in the 404 
latter case (Oh et al., 2012a). These results suggest that the fermentative and respiratory 405 
pathways might have evolved to complement each other for optimal control of cell growth 406 
under a wide range of aeration conditions except the strictly anaerobic one.  407 
2.4 Carbon catabolite repression  408 
Carbon catabolite repression (CCR) refers to the suppression of the use of less-409 
preferred carbon sources, when a more preferred carbon, most prominently glucose, is 410 
present. Cyclic AMP, cAMP receptor protein (CRP), and the enzyme EIIA
Glc
, an 411 
intermediate in the phosphorylation cascade of the PTS, are key players in the CCR of 412 
enterobacteria. The EIIA
Glc
, a cytosolic protein, exists in phosphorylated and 413 
unphosphorylated forms. The phosphorylated form stimulates membrane-bound adenylate 414 
cyclase, which catalyzes the formation of cAMP; the cAMP-CRP complex then induces 415 
expression of the catabolic genes of less-preferred carbon sources. The unphosphorylated 416 
form of EIIA
Glc
 is also responsible for inhibiting the transport of less-preferred carbon 417 
sources by inhibitory binding to permeases, causing so-called inducer exclusion (Eppler and 418 
Boos, 1999; Eppler et al., 2002). Glycerol assimilation in K. pneumoniae is greatly inhibited 419 
by CCR in the presence of glucose. This repression is related to not only low cAMP and 420 
cAMP-CRP but also inhibition of GlpK (which functions mainly under aerobic conditions) 421 
by fructose 1,6-bisphosphate, a metabolite produced from glucose. The unphosphorylated 422 
EIIA
Glc
 is also known to allosterically inhibit GlpK (Holtman et al., 2001). Anaerobic 423 
glycerol metabolism mediated by the dha operons is also suppressed by the presence of 424 
glucose. Enzyme-level inhibition similar to that of the aerobic GlpK has not been reported, 425 
but we have observed that, in K. pneumoniae, transcription of the dha operons is greatly 426 
reduced in the presence of glucose (Suman et al., 2017).  427 
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Interestingly, glycerol exerts catabolite repression on the assimilation of maltose in E. 428 
coli. To exert catabolite repression, glycerol must be phosphorylated to glycerol-3-phosphate 429 
(Hogema et al., 1998; Eppler et al. 2002). However, unlike other carbon sources, further 430 
metabolism of glycerol is not required. According to Eppler and Boos (1999), glycerol-3-431 
phosphate reduces expression of MalT, a positive activator of all mal genes. The key players 432 
in this repression are adenylate cyclase, EIIA
Glc
, and CRP. The growth on maltose of the 433 
mutants lacking EIIA
Glc
 or containing truncated adenylate cyclase was no longer repressed by 434 
glycerol, and CRP-independent transcription of malT was also not influenced by glycerol 435 
either. In addition, stimulation of adenylate cyclase by phosphorylated EIIA
Glc
 was controlled 436 
by glycerol-3-phosphate. The mutation in adenylate cyclase relieved the repression caused by 437 
glycerol-3-phosphate (Eppler et al., 2002). Although not investigated, we assume that the 438 
glycerol repression on maltose catabolism also hold true in K. pneumoniae.  439 
Glycerol also exerts catabolite repression on the assimilation of citrate in K. 440 
pneumoniae. Citrate can be used as the sole carbon and energy source during anaerobic 441 
growth of K. pneumoniae, but the presence of glycerol suppresses the expression of the 442 
citrate fermentation genes. A reduced concentration of the cAMP–CRP complex has been 443 
postulated to be the cause of this repression (Meyer et al., 2001). Further research is needed 444 
to test the hypothesis. 445 
3. K. pneumoniae as a microbial cell factory for the production of commodity chemicals 446 
During glycerol fermentation, K. pneumoniae produces many metabolites, including 447 
PDO, BDO, and lactic acid. This section describes the biotechnological production of bulk 448 
chemicals from glycerol in K. pneumoniae. 3-HP is not a natural product during the growth 449 
of K. pneumoniae on glycerol. However, its production is possible using a minor 450 
modification of the PDO synthetic pathway and is included here. The biochemical pathways 451 
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used for the synthesis of these chemicals are explained, and the metabolic engineering used to 452 
improve their production is discussed.  453 
3.1 1,3-Propanediol 454 
PDO, also known as trimethylene glycol, is a promising platform chemical that has 455 
two hydroxyl groups. With terephthalic acid, it can be co-polymerized to the novel co-456 
polymer polytrimethylene terephthalate (PTT). PDO also has applications in the food and 457 
cosmetic industries. Currently, commercial PDO is mainly produced by recombinant E. coli 458 
(Maervoet et al., 2011; Saxena et al., 2009). The global demand for PDO was 60.2 kilotons in 459 
2012 and is predicted to reach approximately 150 kilotons by 2019. The market for PDO is 460 
growing rapidly, from $157 million in 2012 with projections up to $560 million in 2019 461 
(MarketsANDMarkets, 2012; Lee et al., 2015).  462 
K. pneumoniae is one of the best native producers of PDO from glycerol. GDHt and 463 
PDOR are two important enzymes for the conversion of glycerol to PDO (Fig. 3). 464 
Physiologically, the synthesis of PDO from glycerol is essential for the anaerobic growth of 465 
K. pneumoniae, as described previously. The production of PDO requires two cofactors, 466 
coenzyme B12 and NAD(P)H. K. pneumoniae has a de novo pathway for the biosynthesis of 467 
coenzyme B12 that comprises more than 20 genes. NAD(P)H is generated through the 468 
oxidative metabolism of glycerol, during the production of cell biomass and/or oxidized 469 
(pyruvate and acetate) or partially reduced (BDO, lactic acid) metabolites. The production 470 
yield of PDO from glycerol varies depending on the cost of carbon for NAD(P)H production; 471 
the lower the cost, the higher the yield of PDO from glycerol. NADPH can also be the 472 
electron donor for the conversion of 3-HPA to PDO when YqhD is present. However, the 473 
contribution of NADPH to PDO production in native K. pneumoniae seems to be limited 474 
because the PP pathway, which is the main source of NADPH, is not active when glycerol is 475 
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the sole carbon source. Furthermore, K. pneumoniae has very low transhydrogenase activity 476 
for the conversion of NADH to NADPH (Zhang and Xiu, 2009; Chen et al., 2011).  477 
Several metabolic engineering strategies have been employed to improve PDO 478 
production by K. pneumonia (Table 2). Amplification of the reductive pathway by 479 
overexpressing DhaB, PDOR, or both has been attempted by many research groups. As 480 
indicated previously, 3-HPA is highly toxic, and its accumulation is detrimental to cell 481 
viability and toxic to PDO production. To reduce 3-HPA accumulation, overexpression of 482 
dhaT has been attempted. In one study, 3-HPA accumulation was reduced by dhaT 483 
overexpression, but no improvement in PDO production resulted (Hao et al., 2008). 484 
Overexpression of both DhaT and DhaD increased PDO production (56.3%) in batch culture 485 
but no increase in fed-batch culture (Chen et al., 2009). With another K. pneumoniae strain, 486 
DSM 2026, the same experiments were repeated but also with no increase in PDO production 487 
(Zheng et al., 2006). These results suggest that the reductive pathway in K. pneumoniae is 488 
evolutionarily well established (perhaps in concert with the oxidative pathway) and that PDO 489 
production is not limited by expression of the dhaB and dhaT genes of the reductive pathway. 490 
However, in one study where the E. coli yqhD gene was highly overexpressed to give ~10-491 
fold higher PDOR activity (110 IU/mg total protein), a significant increase in PDO titer (25%; 492 
67.6 g/L) and yield (from 0.53 to 0.62 mol/mol), along with less 3-HPA accumulation, was 493 
achieved (Zhu et al., 2009). This observation suggests that in the recombinant strain, NADPH 494 
can play an important role as a cofactor and that PDO production can be increased by 495 
modifying the reductive pathway. It is also probable that the effect of DhaB and PDOR on 496 
PDO production is highly dependent on the strain and/or culture conditions adopted. 497 
Lactic acid, BDO, ethanol, and acetic acid are the major byproducts of PDO synthesis 498 
in K. pneumoniae. Inactivation of the metabolic pathways that give rise to these products has 499 
resulted in increased PDO synthesis. In particular, deletion of the ldhA gene encoding lactate 500 
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dehydrogenase has been highly beneficial. For example, by disrupting the ldhA gene, Xu et al. 501 
(2009b) significantly increased PDO production without lactic acid production. They 502 
observed increases in the PDO titer (95.4–102.1 g/L), conversion yield (0.48–0.52 mol/mol), 503 
and productivity (1.98–2.13 g/L h; Table 2). Similarly, Oh et al. (2012a) achieved the high 504 
PDO titer of 102.7 g/L by deleting ldhA in their own K. pneumoniae isolate. When lactic acid 505 
production was eliminated, more ethanol and succinic acid were generated from the pyruvate 506 
node. Reduction of these compounds has also been attempted by deleting adhE (encoding 507 
alcohol dehydrogenase) and frdA (encoding fumarate reductase). Although the production of 508 
ethanol and succinate was substantially reduced in the triple mutant (∆ldhA∆adhE∆frdA), 509 
PDO production was only marginally increased compared with that of the single ∆ldhA 510 
mutant. The failure of the triple mutant (∆ldhA∆adhE∆frdA) to increase PDO production was 511 
mainly due to an increase in BDO production. Disruption of the BDO pathway encoded by 512 
the bud operon (budA, budB, and budC) has also been studied (Fig. 5). Although partially 513 
effective, individual inactivation of each of the three genes did not successfully decrease 514 
BDO production (Oh et al., 2012a; Wu et al., 2013). Deletion of the entire bud operon 515 
completely eliminated BDO synthesis (Kumar et al., 2016), but seriously hampered cell 516 
growth and glycerol consumption. Consequently, no increase in PDO production was resulted. 517 
Wu et al. (2013) attempted to decrease BDO production while increasing PDO production by 518 
inserting the fdh gene from Candida boidinii (NADH-forming formate dehydrogenase) into 519 
the budC locus. This protocol increased the PDO titer (62.3–72.2 g/L) and yield (0.47–0.57 520 
mol/mol) and decreased the production of BDO by 52.2% and formic acid by 73.4%.  521 
Acetic acid is one of the most toxic metabolites, accumulating in large quantities 522 
during glycerol fermentation by K. pneumonaie (Celińska, 2012). The toxic effects of acetate 523 
is realized even at the low concentration of 20 mM. Physiologically, acetate is a preferred 524 
metabolite for many Enterobacter sp. because its production is accompanied by ATP 525 
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generation. In a typical bioreactor run for PDO production by K. pneumoniae, the 526 
accumulation of acetic acid to >300 mM by the end is not uncommon, which often 527 
completely stops glycerol fermentation. Acetate is produced by Pta-Ack and PoxB when 528 
pyruvate formation is faster than its consumption, which is so-called ‘overflow metabolism’ 529 
(Fig. 6) (De Mey et al., 2007). In K. pneumoniae, the contribution of the poxB gene is not 530 
significant and its deletion does not much affect acetate production. In comparison, deletion 531 
of the pta-ack genes greatly reduces cell growth and results in high accumulation of pyruvate 532 
and pyruvate-based metabolites (Ko et al., 2017). Extensive studies to reduce or eliminate 533 
acetate production have been conducted in E. coli. Compared to poxB, ackA and/or pta were 534 
much more significant in reducing acetate production. However, deletion of the latter genes 535 
was not beneficial because the glycolytic flux and cell yield were seriously reduced and the 536 
accumulation of other byproducts such as pyruvate, lactate, and formate was greatly 537 
increased (Causey et al., 2004; De Mey et al., 2007). Several indirect approaches to 538 
decreasing pyruvate/acetate accumulation were investigated: stimulation of the anaplerotic 539 
pathway by overexpression of pyruvate carboxylase, PEP carboxylase, or PEP carboxykinase 540 
(Abdel-Hamid et al., 2001; Causey et al., 2004; Chao and Liao, 1993; Sanchez et al., 2005); 541 
overexpression of acetyl-CoA synthetase (ACS); increase of the TCA cycle throughput by 542 
deleting the transcriptional repressor arcA gene; and stimulation of the glyoxylate shunt by 543 
deleting the transcriptional repressor iclR gene (De Mey et al., 2007; Jeong et al., 2004; Lin et 544 
al., 2006). Moreover, the use of a mutant pyruvate dehydrogenase which is less sensitive to 545 
inhibition by NADH has also been examined (Kim et al., 2008). In E. coli, these approaches 546 
proved to be effective to varying extents under properly selected culture conditions. However, 547 
they have not yet been fully investigated in K. pneumoniae.  548 
To eliminate byproduct formation, reduction of glycerol flux through the oxidative 549 
pathway at the glycerol node has also been attempted. The deletion of glycerol 550 
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dehydrogenase (dhaD) and/or dihydroxyacetone kinase (dhaK) resulted in decrease of the 551 
oxidative flux and increase of the conversion yield of glycerol to PDO. In addition, 552 
production of the byproducts lactate, ethanol, and succinate but not acetate decreased 553 
significantly, even without blocking the pathways leading to these byproducts (Seo et al. 554 
2009; Horng et al. 2010). However, cell growth and glycerol consumption rate were also 555 
reduced. Interestingly, in these mutant strains, deletion of dhaT has almost no effect on PDO 556 
production. In the absence of dhaT, expression of an HOR, highly homologous to YqhD, was 557 
upregulated (see section 2.2.4).  558 
The theoretical maximum yields of PDO on glycerol are 0.875 and 0.844 mol/mol 559 
under aerobic and anaerobic conditions, respectively (Celińska, 2012). However, 560 
experimentally, the yields are reported between 0.35 and 0.65 mol/mol (Saxena et al., 2009; 561 
Sun et al., 2008). The low yield is mainly attributed to the accumulation of unnecessary 562 
byproducts and inefficient metabolism for generating reducing equivalents (NADH) and ATP. 563 
If acetyl-CoA is fully oxidized through the TCA cycle (without byproducts formation) and 564 
the activity of the electron transport chain (ETC) oxidizing NADH is properly controlled, a 565 
significant increase in PDO yield is expected. Attaining this goal requires extensive pathway 566 
engineering of cellular metabolism. In bioreactor operation, the aeration rate should be 567 
optimized. Oxygen regulates gene expression and the enzymatic reactions of glycerol 568 
metabolism and determines the diversion of DHA to the PP pathway. Regeneration of NADH 569 
by the TCA cycle and its oxidation by ETC are also controlled by oxygen levels. 570 
3.2 3-Hydroxypropionic acid 571 
As with PDO, 3-HP is an important platform chemical and has been selected by the 572 
US Department of Energy (DOE) as one of the top 12 chemicals obtainable from biomass. 3-573 
HP is a C3 bifunctional molecule and a structural isomer of lactic acid (Werpy and Petersen, 574 
2004). 3-HP can be converted into a variety of useful chemicals such as acrylic acid and acryl 575 
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amide (Pina et al., 2011; Kumar et al., 2013a). 3-HP can be synthesized by chemical routes 576 
from acrylic acid, 3-propiolactone, 3-hydroxypropionitrile, allyl alcohol, vinyl acetate, and 577 
PDO. However, none of the chemical processes is commercially feasible at present due to the 578 
high cost of the starting materials, toxicity of intermediates, and/or the environmental 579 
incompatibility of the processes (Jiang et al., 2009; Pina et al., 2011; Kumar et al., 2013a). 580 
Many microorganisms, including both prokaryotes and eukaryotes, can naturally synthesize 581 
3-HP as either an intermediate or end product through a range of metabolic pathways. 582 
However, the production of 3-HP by these native microorganisms is too low to be 583 
commercially meaningful (Jiang et al., 2009; Kumar et al., 2013a).  584 
In studies pursuing commercial production of 3-HP, glycerol is first converted to 3-585 
HPA by GDHt. 3-HPA then is converted to 3-HP via the coenzyme A (CoA)-dependent or 586 
CoA-independent pathway (Fig. 3). In the CoA-independent pathway, 3-HPA is oxidized to 587 
3-HP by aldehyde dehydrogenase (ALDH); in the CoA-dependent pathway, 3-HPA is 588 
converted to 3-HP via 3-HP-CoA and 3-HP-phosphate. In K. pneumoniae, both the CoA-589 
dependent and CoA-independent pathways are present. However, the titer of 3-HP produced 590 
by the CoA-dependent pathway is low as <5.0 g/L (Luo et al., 2011 and 2012). High 591 
production of 3-HP requires the disruption of oxidoreductases (e.g., DhaT, YqhD) and the 592 
overexpression of a proper aldehyde dehydrogenase (ALDH). Ashok et al. (2013a) developed 593 
a recombinant K. pneumoniae in which dhaT and yqhD were deleted, and the homologous 594 
puuC gene encoding the NAD
+
-dependent -glutamyl--aminobutyraldehyde dehydrogenase 595 
was overexpressed. The recombinant K. pneumoniae produced 3.8 g/L 3-HP in 12 h of flask 596 
culture, but only under appropriate aeration (i.e., microaerobic) conditions. Under anaerobic 597 
conditions, PDO (instead of 3-HP) was obtained as the main product, even though two 598 
oxidoreductases were disrupted and puuC was highly overexpressed. In contrast, highly 599 
aerobic conditions produced a high cell mass without much accumulation of either 3-HP or 600 
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1,3-PDO. In a glycerol-fed batch bioreactor experiment under a constant dissolved oxygen 601 
(DO) concentration of 5% (considered “proper” microaerobic condition), the recombinant K. 602 
pneumoniae ΔdhaT ΔyqhD overexpressing both PuuC and DhaB produced >28 g/L 3-HP in 603 
48 h, with a yield of >40%. In contrast, the same strain produced only 10.5 g/L 3-HP when 604 
cultivated under the higher 10% DO conditions. Several important conclusions regarding 3-605 
HP production by K. pneumoniae were made, as follows. First, in addition to DhaT and 606 
YqhD, K. pneumoniae has more unidentified oxidoreductases that can produce PDO from 3-607 
HPA. Second, to produce 3-HP rather than PDO, proper aeration to regenerate NAD
+
 is 608 
essential. Third, excessively high aeration decreases the expression of the Dha regulon and 609 
synthesis of coenzyme B12, an essential cofactor for GDHt catalysis.  610 
To eliminate PDO production even under limited aeration conditions, Ko et al. 611 
attempted to identify and disrupt other potential PDORs from K. pneumoniae (Ko et al., 612 
2015). A mutant strain devoid of dhaT, yqhD, ahpF, and adhE genes was developed; 613 
however, the mutant neither eliminated 1,3-PDO production nor increased 3-HP production. 614 
Again, this result suggests that K. pneumoniae has more unidentified oxidoreductases, and 615 
thus, the complete elimination of 1,3-PDO production during 3-HP production is highly 616 
challenging. To address the important problem, of NAD
+
 regeneration and coenzyme B12 617 
production, Ashok et al. (2013b) studied anaerobic respiration using nitrate as an external 618 
electron acceptor. They attempted to regenerate NAD
+
 from NADH by nitrate reduction 619 
while maintain anaerobic conditions to synthesize and stabilize the oxygen-sensitive 620 
coenzyme B12. Disruption of the glpK gene (encoding for glycerol kinase) was also necessary 621 
because with glpK intact, the rate of anaerobic respiration was too fast, and most of the 622 
glycerol was metabolized through GlpK to produce biomass, as in the case of highly aerobic 623 
cultivation. The anaerobic glycerol fermentation in the presence of nitrate was successful: 624 
1.74 g/L 3-HP was obtained from a 12-h flask culture and 22 g/L 3-HP was produced in a 48-625 
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h fed-batch bioreactor culture (Ashok et al., 2013b) (Table 3). However, disadvantages were 626 
noted, including the requirement for large amounts of nitrate and the toxic effect of nitrite 627 
generated as a reduced intermediate of nitrate. In a recent study, Li et al. (2016) optimized a 628 
promoter for ALDH expression, culture conditions, and metabolic flux to achieve high-level 629 
production of 3-HP in their K. pneumoniae isolate. One recombinant strain, K. pneumoniae 630 
(pTAC-puuC) expressing puuC under the IPTG-inducible tac promoter, produced 73.4 g/L 3-631 
HP in a bioreactor with a molar yield of glycerol of 0.52 and productivity of 1.53 g/L h. 632 
Further, elimination of the ldh1, ldh2, and pta genes elevated the titer and molar yield to 83.8 633 
g/L 3-HP and 0.54 mol/mol, respectively, with decreased cell growth and productivity. This 634 
titer of 3-HP is the highest produced by K. pneumoniae to date. 635 
As another approach to addressing the problem associated with NAD
+
 regeneration 636 
and coenzyme B12 synthesis in 3-HP production, co-production of 3-HP and PDO has been 637 
investigated. The simultaneous production of 3-HP and PDO can eliminate the dependency 638 
on oxidative metabolism of glycerol (and electron transport chain), as the cofactor required 639 
for 3-HP production is regenerated by PDO production or vice versa. Furthermore, the 640 
problems associated with the expression of genes for the assimilation of vitamin B12 and 641 
glycerol can be alleviated substantially because co-production can be performed under 642 
anaerobic or microaerobic conditions (Kumar et al., 2012, 2013b). Ashok et al. (2011) 643 
developed a recombinant strain of K. pneumoniae DSMZ by overexpressing ALDH and 644 
deleting dhaT. With dhaT intact, PDOR activity was too high compared with that of ALDH, 645 
even with overexpression of the latter enzyme from a multicopy plasmid. The recombinant K. 646 
pneumoniae DSMZ accumulated 16.0 g/L 3-HP and 16.8 g/L PDO in 24 h, and the 647 
cumulative yield of these two metabolites on glycerol was 51% (Table 3). Huang et al. (2012) 648 
studied the same co-production using their K. pneumoniae isolate overexpressing ALDH and 649 
obtained 24.4 3-HP and 49.9 g/L PDO, respectively, after 24 h under anaerobic conditions. 650 
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The cumulative molar yield of the two metabolites reached 0.61 (0.18 for 3-HP and 0.43 for 651 
PDO). In a following study, they showed that the maximum titer of 48.9 g/L 3-HP (along 652 
with 25.3 g/L PDO) was achieved at 1.5 vvm, while the highest concentration of 38.4 g/L 653 
PDO (along with 16.6 g/L 3-HP) was obtained at 0.1 vvm (Huang et al., 2013a).  654 
During 3-HP production from glycerol by K. pneumoniae, the accumulation of such 655 
byproducts as lactic acid, ethanol, acetic acid, formic acid, and 2,3-BDO is a serious 656 
consideration, as in the case of 1,3-PDO production (Ashok et al., 2013a,b; Li et al., 2016). 657 
Deletion of ldhA reduces lactic acid formation and increases the 3-HP yield. However, 658 
deletion of other genes such as adhE, pfl, budBAC, and pta-ack had little desired effect and 659 
seriously hampered cell growth and glycerol assimilation (unpublished data). Even with the 660 
co-production of 3-HP and 1,3-PDO, where oxidative glycerol assimilation was greatly 661 
reduced, accumulation of these byproducts was a serious drawback (Ko et al., 2017). To 662 
prevent the formation of lactic acid along with other byproducts, Kumar et al. (2013b) 663 
employed resting cells of recombinant K. pneumoniae J2B overexpressing ALDH and devoid 664 
of lactate dehydrogenase (ldhA). For this strain, final titers of 3-HP and PDO of 22.7 and 23.5 665 
g/L, respectively, were obtained without lactic acid accumulation. The cumulative product 666 
yield increased to 0.77.  667 
In addition to K. pneumoniae, E. coli has been extensively studied for 3-HP 668 
production from glycerol. Several successful results have been reported by Samsung Ltd. Co. 669 
Korea. One study (Chu et al., 2015) used an engineered strain (E. coli W3110 ΔackA-pta 670 
ΔyqhD_dhaB_mutant gabD4) harboring an active ALDH mutant (designated as GabD4) from 671 
Cupriavidus necator, producing 71.9 g/L 3-HP with a productivity of 1.8 g/L h. However, 672 
unlike K. pneumoniae, E. coli does not synthesize vitamin B12 naturally, and it was necessary 673 
to add the coenzyme externally. Furthermore, a significant amount of glucose for cell growth 674 
was required because for E. coli, glycerol is a less-preferred carbon source than glucose. 675 
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Consequently, the researchers at Samsung initially grew cells to a high density (40–300 676 
OD600) on glucose and then produced 3-HP by feeding glycerol (Chu et al., 2015; Kim et al., 677 
2014a). In comparison, K. pneumoniae can produce a high concentration of 3-HP growing 678 
purely on glycerol at a much lower cell concentration (OD600, <20) (Huang et al., 2013a,b; Li 679 
et al., 2016). Together, the use of glucose for cell proliferation, exogenous addition of 680 
expensive cofactor vitamin B12, and low cumulative yield of 3-HP (on glucose plus glycerol) 681 
increase the production cost. Thus, K. pneumoniae can be considered a better biocatalyst than 682 
E. coli. However, for the commercial production of 3-HP, many other factors are important, 683 
including biosafety, process stability, and downstream processing. Further studies to assess 684 
the potential of these strains as hosts for 3-HP production are needed.  685 
3.3 2,3-Butanediol 686 
BDO has many applications in the pharmaceutical, biomedical, and other chemical 687 
industries for the production of printing inks, perfumes, fumigants, spandex, moistening and 688 
softening agents, and plasticizers (e.g., cellulose nitrate, polyvinyl chloride, polyacrylates) 689 
(Celińska and Grajek, 2009; Ji et al., 2011). BDO can also be used as an antifreezing agent 690 
and octane booster for petrol as is or can be converted to useful derivatives such as 1,3-691 
butadiene, and diacetyl and methyl ethyl ketone. 692 
Unlike 3-HP and PDO, BDO is a product of oxidative metabolism. Of the three 693 
stereoisomers of BDO, K. pneumoniae mainly produces the meso form (Ji et al., 2011). BDO 694 
is synthesized from pyruvate via α-acetolactate and acetoin. The C5 intermediate, α-695 
acetolactate, is formed from two molecules of pyruvate by self-condensation catalyzed by α-696 
acetolactate synthase (ALS; budB). α-Acetolactate is decarboxylated to acetoin by α-697 
acetolactate decarboxylase (budA), and acetoin is reduced to BDO by 2,3-butanediol 698 
dehydrogenase/acetoin reductase (budC) using NADH as a reductant. In the presence of 699 
oxygen, α-acetolactate is spontaneously decarboxylated to diacetyl, further reduced to acetoin 700 
30 
 
by action of diacetyl reductase, and then reduced to BDO. α-Acetolactate is also the precursor 701 
of branched-chain amino acids (valine, leucine, and isoleucine); thus, elimination of the bud 702 
operon can arrest K. pneumoniae growth when cultured on glycerol minimal medium (Kumar 703 
et al., 2016). In the anaerobic process, one NADH molecule is required for the conversion of 704 
two pyruvates to one BDO, while the aerobic process requires two NADH (Fig. 5). The 705 
enzyme DhaD may also contribute to BDO formation (see Section 2.2.1). In the BDO 706 
pathway itself, the conversion of two pyruvates to BDO regulates or is regulated by the 707 
intracellular NADH/NAD
+
 ratio, similar to other fermentative pathways. Another important 708 
role of the BDO pathway is to reduce intracellular acidification by converting acids to the 709 
neutral metabolite, BDO (Celińska and Grajek, 2009; Ji et al., 2011). 710 
Although BDO is one of the main byproducts of glycerol fermentation by K. 711 
pneumoniae (Petrov and Petrova, 2009; Durgapal et al. 2014), its production from glycerol 712 
has not been studied extensively. In few studies using glycerol as the carbon source, Petrov 713 
and Petrova (2009) focused on the effects of pH and aeration with their K. pneumoniae 714 
isolate G31. BDO production was greatest at alkaline initial pH when tested at a pH range of 715 
5–8. Without pH control a sharp pH drop occurred initially due to the production of organic 716 
acids, and this pH drop triggered the synthesis of BDO, which is considered the only non-717 
inhibitory compound produced by the oxidative metabolism of glycerol. Once neutral pH is 718 
restored with the rising concentration of BDO, catabolism shifted toward the production of 719 
ATP-generating acetic acid. The amount of BDO generated in each cycle (pH drop and 720 
neutralization) was dependent on the extent of the pH drop. In one study, a BDO 721 
concentration of 49.8 g/L was reached when the initial pH was set at 8.0 and no pH control 722 
was given during the rest of fermentation. PDO was the major byproduct (11.6 g/L) (Table 4) 723 
and its production decreased by exclusion of Co
2+
, an essential component of coenzyme B12. 724 
They also found that intensive aeration led to a significant increase in BDO production; an 725 
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increase in aeration rate from 1.1 to 2.2 vvm enhanced the yield from 0.38 to 0.46 mol/mol 726 
and productivity from 0.24 to 0.36 g/L h. BDO production was also increased by forced pH 727 
fluctuations of the culture medium with discrete ∆pH values (1.0, 2.0, and 3.0) at 728 
predetermined time intervals (6, 12, and 24 h). The highest BDO concentration (70.0 g/L) 729 
was produced by increasing the pH by one unit (∆pH = 1.0) every 12 h (Petrov and Petrova, 730 
2010). The mechanism behind the effect of this peculiar pH change on BDO production has 731 
not been elucidated. Although BDO is readily produced from glycerol by K. pneumoniae, the 732 
volumetric productivity is low due to the long fermentation time (generally >150 h). Huang et 733 
al. (2013b) isolated two Klebsiella strains that produce BDO plus acetoin with a total yield of 734 
0.44–0.45 (g/g). One isolate utilized 64.5 g/L glycerol in 78 h and produced 24.9 g/L BDO, 735 
3.9 g/L acetoin, and 3.2 g/L ethanol. Again, the volumetric productivity was not high.  736 
Metabolic engineering efforts with K. pneumoniae to improve BDO production from 737 
glycerol are limited. Using glucose as carbon source, Kim et al. (2014b) reported that 738 
overexpression of the BDO pathway (budA, budB) in the ldhA deficient K. pneumoniae strain 739 
KCTC2242 improved BDO production and resulted in 90 g/L BDO, with a productivity of 740 
2.75 g/L. h. Because both glucose and glycerol are converted through the common 741 
intermediate pyruvate, BDO production from glycerol is also expected to increase by 742 
amplification of the bud operon. Further work with glycerol as carbon source is required to 743 
prove this effect. Recently, co-production of BDO and PDO from glycerol has also been 744 
attempted (Park et al., 2017). In glycerol fermentation, both alcohols always appear 745 
simultaneously and co-production seems to be beneficial for cells to maintain redox balance 746 
during anaerobic growth. Park et al. (2017) found that by using the K. pneumoniae mutant 747 
deficient of ldhA and mdh, 50.1 g/L BDO was produced along with 63.8 g/L PDO in 75 h. 748 
The ratio of the two alcohols varied according to aeration; with increasing aeration, the ratio 749 
of [BDO]/[PDO] increased as observed by Petrov and Petrova (2010). In the 5,000 L pilot-750 
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scale fed-batch fermentation using crude glycerol, they could produce 114 g/L diols (70 g/L 751 
PDO and 44 g/L BDO) with the yield of 0.60 diols/glycerol (g/g) and a productivity of 2.2 752 
g/L. h of diols. If separation is not an issue, co-production of the two diols can be a good 753 
option.  754 
3.4 Lactic acid 755 
Lactic acid has applications in the food, chemical, cosmetic, and pharmaceutical 756 
industries. Lactic acid is a monomer that can be polymerized to yield the biodegradable 757 
plastics polylactic acid (PLA) and poly(3-hydroxybutyrate-co-lactate). Two optical isomers 758 
of lactic acid, D- and L-lactic acid, are produced in racemic mixtures depending on the 759 
chemical route used. Microbial fermentation can yield optically pure isomers. Currently, 760 
nearly all commercial lactic acid comes from microbial fermentation (Abdel-Rahman et al., 761 
2013; Abdel-Rahman and Sonomoto, 2016).  762 
Because of the availability of highly efficient lactic-acid–producing microbes derived 763 
from E. coli, lactic acid bacteria, and even acid-tolerant yeasts (Abdel-Rahman et al., 2013), 764 
K pneumoniae has received little attention as a lactic acid producer. However, as previously 765 
described, lactic acid is a major byproduct of glycerol fermentation by K. pneumoniae, and its 766 
potential as a producer is high. This bacterium contains metabolic pathways for the 767 
production of both L- and D-isomers (Fig. 7). They are synthesized through the pyruvate 768 
and/or methylglyoxal pathways in K. pneumoniae (Ashok et al., 2011). When produced from 769 
pyruvate, lactate dehydrogenase (ldhA) reduces pyruvate using NADH as reductant. In the 770 
methylglyoxal route, DHAP is converted to methylglyoxal, which can be transformed to both 771 
D- and L-lactic acid. For the production of L-lactic acid, methylglyoxal is reduced to L-772 
lactaldehyde, which is subsequently oxidized to L-lactic acid. Using glutathione, D-lactic acid 773 
is obtained through simultaneous aldehyde group oxidation and keto group reduction of 774 
methylglyoxal (Booth et al., 2003; Booth, 2005). The methylglyoxal route has several 775 
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disadvantages. Methylglyoxal is highly toxic, and its accumulation can severely impair other 776 
metabolisms and even lead to cell death. Second, the route is energetically inefficient, with an 777 
ATP yield of −1. The L- or D-lactic acid product can be converted back into pyruvate by 778 
respiratory lactate dehydrogenase (Mazumdar et al., 2010, 2013).  779 
Several studies showing the potential of K. pneumoniae as a lactic acid producer are 780 
available (Table 4). For example, K. pneumoniae DSMZ is reported to accumulate 22.7 g/L 781 
lactic acid in 24 h during co-production of 3-HP and PDO from glycerol. The titer of lactic 782 
acid was more than that of any of the targeted products, and the yield of lactic acid on 783 
glycerol alone was 0.31 (Ashok et al., 2011). Similarly, fed-batch cultivation of K. 784 
pneumoniae BLh-1 under oxygen-limited conditions gave lactic acid as the main product, 785 
outcompeting PDO; 59 g/L lactic acid was produced in 40 h when crude glycerol from 786 
biodiesel synthesis without any purification was used (Rossi et al., 2013). Durgapal et al. 787 
(2014) also found that K. pneumoniae J2B and DSMZ strains produced lactic acid at 37.0 and 788 
47.8 g/L, respectively (Table 4); in both strains, lactic acid levels surpassed those of the target 789 
product PDO. Recently, Feng et al. (2014) engineered K. pneumoniae ATCC25955 by 790 
overexpressing ldhA and deleting dhaT and yqhD (recall that these two genes are mainly 791 
responsible for PDO production). They found that the recombinant produced 142.1 g/L of 792 
optically pure D-lactic acid from glycerol in fed-batch cultivation under microaerobic 793 
conditions (2.5 vvm and 400 rpm). This result is the highest lactic acid concentration 794 
produced from glycerol reported to date. E. coli has also been engineered for the production 795 
of D- and L-lactate from glycerol (Mazumdar et al., 2010, 2013). For diverting glycerol flux 796 
toward L-lactic acid in E. coli, the chromosomal copy of D-lactate dehydrogenase was 797 
replaced with Streptococcus bovis L-lactate dehydrogenase (Mazumdar et al., 2013). 798 
Moreover, gene encoding lldD (respiratory L-lactate dehydrogenase) was inactivated to 799 
prevent the consumption of L-lactic acid, and the methylglyoxal route (∆mgsA) was blocked 800 
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to prevent production of toxic methylglyoxal and formation of racemic mixtures of D- and L-801 
lactic acid (Fig. 7). Furthermore, the respiratory route for glycerol assimilation was 802 
overexpressed (glpK and glpD) to improve the ATP yield of the metabolic pathway through 803 
transfer of electrons from glycerol-3-phosphate to oxygen (i.e., oxidative phosphorylation). 804 
The engineered E. coli strain (∆pflB ∆pta ∆adhE ∆frdA ∆mgsA ∆lldD ∆ldhA::ldhA_glpK-805 
_glpD) produced 50 g/L of L-lactate from 56 g/L of crude glycerol, at a yield 93% of the 806 
theoretical maximum and with high optical (99.9%) and chemical (97%) purity (Mazumdar et 807 
al., 2013). The approaches proven successful in E. coli should be applicable to K. 808 
pneumoniae. These studies, along with the results by Feng et al. (2014), suggest that K. 809 
pneumoniae is a good host for the production of D- and L-isomers of lactic acid, with high 810 
optical purity, from glycerol. 811 
3.5 Ethanol and other metabolites 812 
K. pneumoniae has also been studied for the production of ethanol, succinic acid, 2-813 
ketogluconic acid, catechol, cis,cis-muconic acid and 2-butanol although its potential for such 814 
production has not been fully explored (Cheng et al., 2013; Jung et al., 2015; Oh et al., 2014; 815 
Wang et al. 2015; Wei et al., 2013). Of these chemicals, ethanol production has been 816 
relatively well studied. Ethanol is a renewable energy source and is widely used as a fuel 817 
additive for partial gasoline replacement. Currently, commercial ethanol is produced from the 818 
fermentation of sugar and starch. However, glycerol is one of the cheapest substrates for 819 
ethanol production, estimated as nearly 40% cheaper than sugar-based production (Yazdani 820 
and Gonzalez, 2007). This factor has encouraged the development of microbial strains for 821 
fermentative conversion of glycerol to ethanol. The metabolic route by which ethanol is 822 
synthesized from glycerol is shown in Fig. 6. Oh et al. (2011, 2012b) constructed a mutant 823 
strain of K. pneumoniae (termed GEM167) through -irradiation. PDO synthesis in this 824 
mutant strain was lower than that of wild type (0.2 vs. 7.93 g/L, respectively), while ethanol 825 
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accumulation was higher (8.6 vs. 1.1 g/L, respectively). The mechanism underlying these 826 
changes remains unclear. Introduction of the pyruvate decarboxylase (pdc) and aldehyde 827 
dehydrogenase (adhII) genes into mutant strains lacking lactate dehydrogenase (ldhA) 828 
resulted in the production of 31.0 g/L (673.9 mM) ethanol, with a yield of 0.89 (mol/mol) and 829 
productivity of 1.2 g/L h (Oh et al., 2012b), the highest level of ethanol production from 830 
glycerol reported to date. More extensive studies including estimation of the maximum 831 
achievable titer and microbial tolerance to high-concentration ethanol, both of which are key 832 
factors for commercialization, are required to assess the potential to produce ethanol from 833 
glycerol by the use of K. pneumoniae. 834 
4. Challenges to bioconversion of glycerol using K. pneumoniae as a biocatalyst  835 
The design of microbial cell factories is gaining unprecedented momentum as 836 
metabolic engineering is progressively aided by advances in synthetic biology and multi-837 
omics analyses. Several bio-based chemicals have already been launched successfully in the 838 
marketplace, and others are in the pipeline. For a bulk chemical to be considered for 839 
commercial production, the production process should achieve a product concentration of 100 840 
g/L, carbon yield of 0.50 (g/g), and volumetric productivity of 2.0 g/L/h. The aforementioned 841 
products produced by K. pneumoniae from glycerol are no exception. Challenges to the use 842 
of K. pneumoniae as a microbial cell factory using glycerol as a carbon source are described. 843 
4.1 Pathogenicity 844 
The pathogenicity of K. pneumoniae is one of the major obstacles to its commercial 845 
application. K. pneumoniae is a Bio-safety Level 2 microorganism and causes nosocomial 846 
and urinary tract infections. Moreover, capsulated K. pneumoniae cells are difficult to 847 
separate from culture broth, complicating the downstream processing. The biotechnological 848 
application of this bacterium will require attenuation of its pathogenicity and reduction of 849 
biosafety concerns. K. pneumoniae produces a number of virulence factors that contribute to 850 
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its pathogenicity, including lipopolysaccharide (LPS), capsular antigens, fimbrial adhesins, 851 
siderophores, and O antigens (Albertí et al., 1993; Fang et al., 2004; Podschun and Ullmann 852 
1998). The mechanism by which this bacterium causes disease is still obscure because most 853 
studies have been conducted on a limited number of virulence factors (El Fertas-Aissani et al., 854 
2013).  855 
In the last decade, efforts have been made to overcome the pathogenicity of K. 856 
pneumoniae (Shrivastav et al., 2013), suggesting hope for the generation of nonpathogenic K. 857 
pneumoniae. The two major pathogenic determinants in K. pneumoniae are the capsular 858 
polysaccharides (CPS), which cover the entire bacterial surface, and LPS, expressed on the 859 
outer bacterial membrane. LPS consists of lipid A, a core oligosaccharide, and an O-antigenic 860 
polysaccharide. In a highly virulent strain of K. pneumoniae, mutations in genes involved in 861 
LPS biosynthesis (waaC, waaF, and wabG) resulted in a decrease in bacterial colonization 862 
and virulence (Izquierdo et al., 2003; Jung et al., 2013). Mutant strains devoid of the outer 863 
core LPS were also found to be deficient in the “cell-attached” capsular polysaccharides 864 
covering the bacterial surface. These mutations abolished the highly virulent characteristics 865 
of pathogenic K. pneumoniae when tested in different animal models. Furthermore, these 866 
mutants were more sensitive to several hydrophobic compounds than were wild-type strains. 867 
Reintroduction of the waaC, waaF, and wabG genes into K. pneumoniae rescued the 868 
pathogenic properties, confirming the role of these genes in pathogenicity.  869 
Another important study was conducted by Lin et al. (2012), in which eight highly 870 
conserved residues of the MagA protein (G308, G310, G334, G337, R290, P305, H323, and 871 
N324) encoded by the mucoviscosity-associated gene A (magA) of K. pneumoniae were 872 
subjected to site-directed mutagenesis. The magA gene contributes to the biosynthesis of K1 873 
capsular polysaccharide (CPS), which correlates with pathogenic phenotypes including 874 
mucoviscosity, serum and phagocytosis resistance, and virulence. Alanine substitutions at 875 
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R290A or H323A abolished MagA function, with annihilation of CPS production, serum 876 
resistance, and virulence. Some K. pneumoniae strains showing less pathogenicity were also 877 
isolated. For example, K. pneumoniae strain J2B produced less LPS and demonstrated a high 878 
sensitivity to many antibiotics and lower pathogenicity. Moreover, its biomass was readily 879 
separated from fermentation broth by centrifugation (Arasu et al., 2011). Future studies 880 
should include further engineering of these less pathogenic strains to make them completely 881 
nonpathogenic, followed by careful evaluation of their toxicity. 882 
4.2 Complex glycerol metabolism 883 
Although glycerol metabolism has been extensively studied, the mechanism and 884 
regulation of its gene expression in K. pneumoniae have not been fully elucidated. The 885 
diversity of glycerol metabolism should be a great advantage for K. pneumoniae survival in 886 
different environments and for its biotechnological utilization as well. However, a high level 887 
of complexity poses difficulty in the engineering of a strain to suit our purposes. Metabolic 888 
complexity is likely responsible in part for the fact that, despite serious attempts, the molar 889 
yield of many important products such as PDO and 3-HP is still far below the theoretical 890 
maximum. Efforts based on our current knowledge, such as the overexpression of DhaB, 891 
DhaT, YqhD and AldH and inactivation/deletion of GlpK, DhaD, DhaK and DhaKLM, were 892 
not satisfactory (Maervoet et al. 2011; Kumar et al. 2013a; Kumar et al., 2016). Another 893 
challenge is to understand how the ratio of glycerol distribution between respiratory and 894 
fermentative routes is controlled. Because the KM of glycerol kinase toward glycerol is low, it 895 
has been speculated that a major fraction of glycerol flows through the respiratory route when 896 
oxygen is present. However, some experimental results do not support this hypothesis. For 897 
example, deletion of glpK does not decrease the glycerol flow through the oxidative pathway 898 
in the presence of oxygen (Ashok et al. 2013a). In fact, wild-type and mutant (∆glpK) strains 899 
of K. pneumoniae demonstrate similar cell growth, glycerol consumption, and PDO 900 
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production profiles under (micro)aerobic conditions. These observations suggest the presence 901 
and/or involvement of other kinases.  902 
Another challenging issue for the use of K. pneumoniae is its inefficient TCA cycle 903 
(Cabelli, 1955). Several genes, including isocitrate dehydrognease (icd), fumarase (fumA), 904 
and malate dehydrogenase (mdh), in K. pneumoniae are significantly less transcribed than 905 
those in E. coli (unpublished data). Furthermore, the activity of isocitrate dehydrogenase was 906 
more than sevenfold lower in K. pneumoniae than in E. coli. If the TCA cycle is inefficient, 907 
achieving a high cell density, which is essential for improving the productivity of target 908 
metabolites, is difficult. Moreover, achieving high-yield generation of NADH with little 909 
consumption of glycerol carbon is difficult. Furthermore, the overflow metabolism that 910 
produces highly toxic acetate becomes more serious. These problems have been well 911 
documented in PDO production. In a recent study, Kumar et al. (2016) attempted to increase 912 
PDO production yield by blocking the lactate and BDO pathways, while diverting carbon 913 
flux through the TCA cycle for efficient regeneration of NADH. However, this effort resulted 914 
in the detrimental accumulation of pyruvate, acetate, and ethanol, causing low NADH 915 
regeneration and low PDO production. Neither increased aeration nor the addition of good 916 
nitrogen sources (complex nitrogen sources) alleviated the accumulation of these 917 
intermediates or activated the TCA cycle. Furthermore, the accumulation of pyruvate quickly 918 
terminated glycerol assimilation. K. pneumoniae has a well-established BDO production 919 
pathway that likely compensates for its inefficient TCA cycle, avoiding the overflow 920 
metabolism and carbon traffic at the pyruvate node. If this is the case, co-production of BDO 921 
along with PDO or 3-HP, rather than single production of PDO or 3-HP, should be more 922 
appropriate, which suits the nature of K. pneumoniae. In fact, when BDO and PDO were co-923 
produced, more PDO was generated than during PDO production alone. More studies are 924 
required to gain a better understanding of glycerol metabolism, the slow operation of the 925 
39 
 
TCA cycle in K. pneumoniae, and its effect on the selection of target products and/or 926 
development of suitable strains and processes. Otherwise, it will be difficult to exploit this 927 
potential biocatalyst for commercial manufacturing of valuable chemicals. 928 
4.3 Toxicity of intermediate metabolites and end-products 929 
A general but major challenge to the use of microbial cell factories for producing bulk 930 
chemicals is the toxic effect of target products and metabolic intermediates at high 931 
concentrations. In particular, during the production of PDO or 3-HP from glycerol, the highly 932 
toxic intermediate 3-HPA is inevitably generated. Aldehydes generally damage DNA, 933 
inactivate enzymes, and inhibit DNA synthesis. 3-HPA causes irreversible cessation of 934 
metabolic activity and cellular growth, even at very low concentrations of 15–30 mM (Hao et 935 
al., 2008; Zheng et al., 2008). Native K. pneumoniae does not accumulate 3-HPA at toxic 936 
levels during PDO production, but in engineered strains that overexpress DhaB, high 3-HPA 937 
accumulation is often experienced. To avoid 3-HPA accumulation, enzymes that consume 3-938 
HPA, ALDH (for 3-HP production), and PDOR (for PDO production) are expressed at 939 
sufficiently (sometimes excessively) high levels compared with that of DhaB (Lim et al., 940 
2016). Intermediates such as methylglyoxal, DHA, DHAP, and glyceraldehyde-3-phosphate 941 
are also known to be toxic. 942 
Organic acids and alcohols are toxic at high concentrations. Generally, organic acids 943 
are more toxic than their corresponding alcohols because they disturb the intracellular pH and 944 
have anion-specific effects on metabolism (Chun et al., 2014; Warnecke and Gill, 2005). 945 
When accumulated in cell membranes, organic compounds damage membrane integrity and 946 
inhibit the activity of membrane-bound enzymes. In K. pneumoniae, cell growth and glycerol 947 
assimilation are severely inhibited by high concentrations of PDO or 3-HP. Furthermore, 948 
enzymes that play major roles in 3-HP and PDO production, such as DhaB, DhaT, and AldH, 949 
are inhibited by 3-HP and PDO (Kumar et al. 2013b). Furthermore, K. pneumoniae is 950 
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sensitive to 24 g/L acetic acid, 26 g/L lactic acid, and 17 g/L ethanol under aerobic conditions 951 
and 15, 19, and 26 g/L, respectively, under anaerobic condition (Celińska, 2012; Cheng et al., 952 
2005). The inhibition of pathways by target product(s) and/or unwanted byproducts often 953 
places a limit on the maximum attainable titer of bulk chemicals. 954 
Several studies have reported engineered improvements in microbial tolerance against 955 
biochemicals and biofuels, especially in E. coli. Modifications of exporter proteins, heat 956 
shock proteins, membrane composition, and stress responses have been attempted. Moreover, 957 
in situ recovery of target products has been attempted for hydrophobic targets. Some tolerant 958 
strains have been developed, but unfortunately, without appreciable increases in productivity 959 
(Dunlop, 2011; Dunlop et al., 2011; Jarboe et al., 2011). Such efforts to improve tolerance to 960 
chemicals have not been reported for K. pneumoniae. 961 
4.4 Availability of glycerol 962 
The global market for glycerol is known to be unpredictable and complex. Glycerol in 963 
the current market mainly is from the biodiesel industry, and its supply is directly affected by 964 
the use of biodiesel. In contrast, glycerol demand depends on many industries that use it as 965 
feedstock. Between 2001 and 2011, the price varied significantly, from $0.70/kg to $1.70/kg 966 
for pure glycerol and from $0.04/kg to $0.33/kg for crude glycerol (Ayoub and Abdullah, 967 
2012; Ciriminna et al., 2014; Kong et al., 2016; Quispe et al., 2013). Nevertheless, glycerol 968 
prices, for pure as well as crude, have come down significantly since 2004, when many 969 
biodiesel production plants initiated operation. The countries producing biodiesel in large 970 
quantities (in million liters) include Germany (2900), Brazil (2300), Argentina (2100), France 971 
(2000), USA (1200), Spain (1100), Italy (800), Indonesia (700), and Thailand (600) (Kong et 972 
al., 2016). The Asia-Pacific region overtook Europe as the largest glycerol market in the 973 
world in 2009 and has remained so ever since. Market growth is driven by increases in the 974 
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uses for glycerol in such sectors as pharmaceuticals, personal hygiene, and food and beverage 975 
production (Quispe et al., 2013).  976 
The production of crude glycerol is expected to reach 6 million tons by 2025 977 
(Ciriminna et al., 2014). At present, the surplus of glycerol from biodiesel and oleochemicals 978 
is assumed to be sufficient to meet these new demands. However, the scenario may change in 979 
the future with rapid growth of glycerol-based industries and a limited supply of crude 980 
glycerol. For example, if 3-HP produced from glycerol were used as a substitute for the 981 
chemical acrylic acid (global production, 5.85 million tons as of 2014), approximately 7 982 
million tons of glycerol/year would be needed. If we include other platform chemicals such 983 
as PDO, BDO, and ethanol, the demand will be even higher, much more than the expected 984 
supply. The growth of glycerol-based biotechnology will eventually be constrained by the 985 
supply and price of crude glycerol as a carbon source. 986 
5. Concluding remarks 987 
Glycerol is an excellent substrate for the production of biochemicals and biofuels. 988 
Although the biodiesel industry has grown rather slowly in recent years, crude glycerol is still 989 
cheap and generated in large quantities. K. pneumoniae has already been successfully 990 
employed for the production of PDO, 3-HP, BDO, lactic acid, and ethanol from glycerol at 991 
industrially attractive levels. Other metabolites such as acetic acid, pyruvic acid, malic acid, 992 
fumaric acid, alanine, n-butanol, 1,2-propanediol, propionic acid, formic acid, and hydrogen 993 
can also be produced from glycerol by K. pneumoniae, although these have not yet been 994 
extensively explored. At present, sugar-based bioprocesses are prevalent, and no bioprocesses 995 
employing K. pneumoniae and glycerol are commercially available. The pathogenicity of K. 996 
pneumoniae and other technical issues are existing challenges to its use. However, 997 
advancements in the fields of metabolic engineering, synthetic biology, systems biology, and 998 
evolutionary engineering will enable us to further exploit the advantageous nature of K. 999 
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pneumoniae as a biocatalyst and glycerol as a carbon source. A better understanding of 1000 
glycerol metabolism in K. pneumoniae and improvements in its performance as a microbial 1001 
cell factory should make this organism an attractive alternative to current sugar-based 1002 
methods for the production of biochemicals and biofuels. 1003 
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Figure captions 1462 
Figure 1: Transformation of glycerol into a number of valuable chemicals. The solid line 1463 
represent single step while broken one indicate multiple steps. 1464 
Figure 2: Oxidative metabolism of glycerol in K. pneumoniae (Ashok et al., 2011; Kumar et 1465 
al., 2013a). Gene names are shown in italics on arrows. Solid lines indicate single steps; 1466 
broken lines indicate multiple steps. 1467 
Figure 3: Metabolic pathways for the production of PDO and 3-HP from glycerol (Ashok et 1468 
al., 2011; Kumar et al., 2013a). Gene names are shown in italics on arrows.  1469 
Figure 4 (A): Arrangement of genes in the dha regulon of K. pneumoniae. 1, dhaK (ATP-1470 
dependent dihydroxyacetone kinase); 2, dhaK3/dhaM (large subunit of ATP-dependent 1471 
dihydroxyacetone kinase); 3, dhaK2/dhaL (small subunit of ATP-dependent 1472 
dihydroxyacetone kinase); 4, dhaK1/dhaK (medium subunits of ATP-dependent 1473 
dihydroxyacetone kinase); 5, orfW (hypothetical protein); 6, dhaD (glycerol dehydrogenase); 1474 
7, dhaR (transcription regulator); 8, orfW/CdAT [cob(I)yrinic acid a,c-diamide 1475 
adenosyltransferase]; 9, orfX/dhaG (small subunit of reactivating factor of glycerol 1476 
dehydratase); 10, dhaT (1,3-propanediol oxidoreductase); 11, orfY (hypothetical protein); 12, 1477 
dhaB/B1 (large subunits of glycerol dehydratase); 13, dhaC/B2 (medium subunit of glycerol 1478 
dehydratase); 14, dhaE/B3 (small subunit of glycerol dehydratase); 15, orfZ/dhaF (large 1479 
subunit of reactivating factor of glycerol dehydratase); 16, glpF (glycerol uptake facilitator); 1480 
17, 22- hdeB; 18, hdeD (hdeBD-genes related to global regulation); 19, yfdX; 20, kvgS; and 1481 
21, kvgA ( kvgS and kvgA encode for a two-component signal transduction system) (Celińska, 1482 
2012; Sun et al., 2003; Wei et al., 2014). (B): Glycerol dehydratase gene arrangements and 1483 
reactivation factors in different organisms (Martins-Pinheiro et al., 2016).  1484 
Figure 5: Metabolic pathway for the synthesis of BDO from glycerol (Ashok et al., 2011; 1485 
Celińska and Grajek, 2009; Ji et al., 2011). Gene names are shown in italics on arrows. Solid 1486 
lines indicate single steps; broken lines indicate multiple steps. 1487 
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Figure 6: Biochemical routes for ethanol and acetic acid production from glycerol (Ashok et 1488 
al., 2011; Kumar et al., 2013a). Gene names are shown in italics on arrow. Solid lines 1489 
indicate single steps; broken lines indicate multiple steps. 1490 
Figure 7: Lactic acid production from glycerol via methylglyoxal and pyruvate routes 1491 
(Ashok et al., 2011; Mazumdar et al., 2010; 2013). Gene names are shown in italics on arrow. 1492 
Solid lines indicate single steps; broken lines indicate multiple steps. 1493 
Fig. S1 Effect of deletion of glycerol transporters, glpF1 and glpF2, on glycerol consumption 1494 
and PDO production in K. pneumoniae J2B3. 1495 
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*glpF1 designates the gene located at the respiratory glpFK operon, while glpF2  indicates a separate operon in the fermentative dha regulon located between orfZ/
dhaF operon and hdeB operon (see Fig. 4A). For the growth of K. pneumoniae J2B3 which is deleted for glpK, glpD, glpA and dhaD (see Fig. 2 for their roles), gluco
se was added at 100 mM because the strain cannot grow on glycerol as the sole carbon source (Lama et al., 2017) 
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Table 1: Comparison of maximum theoretical yield, ATP yield and redox balance during microbiological production of different 
metabolites from glycerol and glucose* 
 
Metabolite Maximum theoretical yield**  ATP generated/Metabolite 
(mol/mol) 
Redox constrained 
[NAD(P)H generated & consumed/ Metabolite] 
Glucose  
(mol/0.5 mol) 
Glycerol 
(mol/mol) 
Glucose 
 
Glycerol 
 
Glucose Glycerol 
1,3-propanediol 
C3H8O2 
0.75 0.88 -1 0 Yes (0 & 2) Yes (0 & 1) 
3-hydroxypropionic acid 
C3H6O3 
1.0 1.17 1/0/-1/-0.33 0/1 No (1 & 1;2 & 2) Yes (1 & 0) 
2,3-butanediol 
C4H10O2 
0.55 0.64 2 2 Yes/No (2 & 1/2) Yes (4 & 1/2) 
Ethanol 
C2H6O 
1.0 1.17 1 1 Yes/No (1/2 & 2) Yes/No (2/3 & 2) 
Succinic acid 
C4H6O4 
0.86 1.0 0/1 0/1 Yes (1 & 2) No (2 & 2) 
Lactic acid 
C3H6O3 
1.0 1.17 1/-1 1/-1 No (1 & 1; 0 & 0) Yes (2 & 0; 1 & 0) 
Pyruvic acid 
C3H4O3 
1.2 1.4 1 1 Yes (1/2 & 0) Yes (2/3 & 0) 
Acetic acid 
C2H4O2 
1.5 1.75 1/2 1/2 Yes (1/2 & 0) Yes (2/3 & 0) 
1-Butanol 
C4H10O 
0.5 0.58 2 2 No (4 & 4) Yes (6 & 4) 
*The variation in ATP yield, NADH generated and consumed is due to formation of metabolite through different routes. 
**The theoretical yields of metabolites were calculated on the basis of degree of reduction (Dugar and  Stephanopoulos, 2011). 
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Table 2: Summary of PDO production from glycerol using different K. pneumoniae strains 
Strain Mode of 
operation 
Carbon 
source(s) 
Aeration 
condition 
Titer 
(g/L) 
Yield 
(mol/mol) 
Productivity 
(g/L. h) 
Reference 
Wild type strains 
K. pneumoniae M5al Batch Glycerol Anaerobic 58.8 0.53 0.92 Cheng et al. 2007 
K. pneumoniae XJPD-Li Fed-batch Glycerol Aerobic 65.3 0.56 3.16 Ma et al. 2009 
K. pneumoniae AC 15 Fed-batch Glycerol Aerobic 74.1 0.62 3.08 Zheng et al. 2008 
K. pneumoniae DSM 2026 Fed-batch Glycerol Anaerobic 81.0 0.64 3.00 Liu et al. 2007 
K. pneumoniae DSM 2026 Fed-batch Glycerol Microaerobic 77.0 0.62 2.70 Liu et al. 2007 
K. pneumoniae HR526 Fed-batch Glycerol Aerobic 95.4 0.48 1.98 Xu et al. 2009b 
K. pneumoniae KG1 Fed-batch Glycerol Aerobic 98.8 0.51 3.29 Zhao et al. 2009 
Mutant strains 
K. pneumoniae HR526 
ΔldhA 
Fed-batch Glycerol Aerobic 102.1 0.52 2.13 Xu et al. 2009b 
K. pneumoniae Cu ΔldhA Fed-batch Glycerol Aerobic 102.7 0.50 1.53 Oh et al. 2012a 
K. pneumoniae YMU2 
ΔaldA 
Fed-batch Glycerol Anaerobic 70.6 0.70 1.1 Zhang et al. 2006 
K. pneumoniae YMU2 Fed-batch Glycerol Anaerobic 72.2 0.57 2.41 Wu et al. 2013 
3 
 
ΔbudC_fdh 
Recombinant strains (Overexpression of Genes from the Reductive Branch) 
K. pneumoniae TUAC01_ 
dhaT 
Batch Glycerol Aerobic 15.0 0.61 1.36 Hao et al. 2008 
K. pneumoniae KG1_ dhaT Fed-batch Glycerol Aerobic 90.9 0.64 2.16 Zhao et al. 2009 
K. pneumoniae ME-
308_yqhD 
Fed-batch Glycerol Microaerobic 67.6 0.62 1.69 Zhu et al. 2009 
K. pneumoniae ΔdhaD 
ΔdhaK ΔdhaT_yqhD 
Batch Glycerol Aerobic 7.7 0.53 0.26 Seo et al. 2010 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 
 
 
 
 
 
 
Table 3: Different strategies carried out for 3-HP production through fed-batch mode 
Strain Carbon 
source(s) 
Aeration 
condition 
Titer* 
(g/L) 
3-HP yield on glycerol 
(mol/mol) 
Productivity 
(g/L. h) 
Reference 
K. pneumoniae DSM 2026  
∆ dhaT_ puuC 
Glycerol Microerobic 16.0 (16.8) 0.23 0.67 Ashok et al. 2011 
K. pneumoniae WM3 
pUC18kan_aldHec 
Glycerol Anaerobic 24.4 (49.3) 0.18 1.02 Huang et al. 2012 
K. pneumoniae J2B _ KGSADH Glycerol Anaerobic 11.3 (15.9) 0.27 0.94 Kumar et al. 2012 
K. pneumoniae  
∆glpK∆dhaT_puuC 
Glycerol Anaerobic 22.0 (5.9) 0.30 0.46 Ashok et al. 2013a 
K. pneumoniae  
∆dhaT∆yqhD_dhaB_puuC 
Glycerol Aerobic 28.1 (3.3) 0.40 0.58 Ashok et al. 2013b 
K. pneumoniae WM3 
pUC18kan_aldHec 
Glycerol Microaerobic 48.9 (25.3) 0.41 1.75 Huang et al. 2013a 
K. pneumoniae J2B 
∆ ldhA _ KGSADH 
Glycerol Microaerobic 22.7 (23.4) 0.35 0.38 Kumar et al. 2013b 
E. coli W3110 ΔackA-pta 
ΔyqhD_dhaB_mutant gabD4 
Glucose & 
glycerol 
Aerobic 71.9 - 1.8 Chu et al. 2015 
K. pneumoniae DSM 2026 
Δ ldh1Δldh2Δpta_puuC (pTAC) 
Glycerol Microaerobic 83.8 (22.1) 0.54 1.16 Li et al. 2016 
*The values shown in the bracket are the PDO concentration obtained along with 3-HP. 
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  Table 4: Comparison of BDO, ethanol and lactic acid production by different strains of K. pneumoniae and other organisms 
 
Strain Mode of 
operation 
Carbon 
source(s) 
Aeration 
condition 
Titer 
(g/L) 
Yield 
(mol/mol) 
Productivity 
(g/L. h) 
Reference 
BDO 
K. pneumoniae G31 Fed-batch Glycerol Microaerobic 49.2 0.37 0.17 Petrov and Petrova, 
2009 
K. pneumoniae G31 Fed-batch Glycerol Aerobic 70.0 0.40 0.47 Petrov and Petrova, 
2010 
Klebsiella sp. 2 Fed-batch Glycerol Aerobic 24.9 0.40 0.34 Huang et al. 2013b 
K. pneumoniae SDM Fed-batch Glucose Aerobic 150.0 0.84 3.93 Ma et al. 2009 
K. pneumoniae KCTC2242 
∆ldhA_budA_budB 
Fed-batch Glucose Aerobic 90.0 0.76 2.75 Kim et al. 2014b 
Ethanol 
K. pneumoniae GEM167 mutant Fed-batch Glycerol Microaerobic 21.5 0.62 0.93 Oh et al. 2011 
K. pneumoniae GEM167 mutant 
∆ldhA_pdc_adhII 
Fed-batch Glycerol Microaerobic 31.0 0.89 1.20 Oh et al. 2012b 
E. coli (nine gene knockout strain) Batch Glycerol Microaerobic 18.0 0.90 0.38 Trinh and Srienc, 
2009 
Lactic acid 
K. pneumoniae DSM 2026  
∆ dhaT_ puuC 
Fed-batch Glycerol Microaerobic 22.7 0.32 0.95 Ashok et al. 2011 
K. pneumoniae J2B Fed-batch Glycerol Microaerobic  28.2 0.28 0.39 Kumar et al. 2013b 
6 
 
∆ ldhA _ KGSADH 
K. pneumoniae BLh-1 Fed-batch Glycerol Microaerobic  59.0 0.48 1.48 Rossi et al. 2013 
K. pneumoniae J2B  Fed-batch Glycerol Microaerobic  37.0 0.32 0.77 Durgapal et al. 2014 
K. pneumoniae DSMZ  Fed-batch Glycerol Microaerobic  47.8 0.39 1.00 Durgapal et al. 2014 
K. pneumoniae ATCC25955 
∆dhaT_ ∆yqhD_ ldhA  
Fed-batch Glycerol Microaerobic  142.1 
(D-isomer) 
0.84 2.96 Feng et al. 2014 
E. coli MG1655 
∆pta_∆adhE_∆frdA-
∆dld_glpK_glpD 
Fed-batch Glycerol Microaerobic 32.0 
(D-isomer) 
0.82 0.54 Mazumdar et al. 2010 
E. coli MG1655  
∆pflB_∆pta_∆adhE_∆frdA 
_∆mgsA_∆lldD_∆ldhA::ldhA_glpK-
_glpD 
Fed-batch Glycerol Microaerobic 50.0 
(L-isomer) 
0.92 0.60 Mazumdar et al. 2013 
 
 
